A American Board of Medical Specialties (ABMS): an organization that certifies physicians as specialists. This group comprises 24 member boards, including the American Board of Plastic Surgery. Rigorous membership standards include educational requirements, professional peer evaluation and exams. American Board of Plastic Surgery (ABPS): the medical specialty board that certifies plastic surgeons. analgesic: a pain reliever. anatomical implant: a contoured or teardrop-shaped implant. anesthesia: a numbing agent. areola: the disc of pigmented skin around the nipple; plural: areolae or areolas. arnica montana: an herb used to treat swelling and bruising. American Society of Plastic Surgeons (ASPS): the professional organization of board-certified plastic surgeons. American Society for Aesthetic Plastic Surgery (ASAPS): the sister organization of the ASPS. All board-certified plastic surgeons are members of ASPS, but ASAPS members specialize in cosmetic surgery. asymmetrical: unequal, unmatching. axilla: the armpit or underarm area; plural: axillae. axillary: related to the armpit or underarm region. B band size: measurement of the rib cage denoted in bra sizes. It is measured in inches. Benelli mastopexy: a type of breast lift performed by removing a circle of skin around the areolae complex and pulling in the breast tissue. Also known as a concentric, periareolar, or donut mastopexy. bilateral: both the right and left sides. For example, a bilateral mastectomy is the surgical removal of both breasts. board certified: an important term regarding the credentials of a physician or surgeon. bottoming out: a condition which occurs when the lower poles (halves) of the breast slide under the inframammary crease. breast envelope: the skin and subcutaneous tissue that covers the breast and helps give it shape. breast lift: also called mastopexy or mastoplexy, the surgical procedure used to raise and firm sagging breasts. bromelain: a homeopathic remedy derived from the pineapple stem which may reduce swelling and bruising. C capsular contracture: a complication that occurs when scar tissue forms around the implant, resulting in painful breast stiffness and possible leakage of the fluid inside the implant. capsule: the fibrous tissue around the breast implant. cleavage: the area between the breasts. cohesive: marked by a tendency to stick together. Cooper’s Ligament: the connective tissue that attaches the breast gland to the overlying skin. cutaneous: relating to or affecting the skin. D dissect: to separate tissue in surgery; to place an implant, your surgeon must first create or dissect a pocket within your breast. E endoscopic surgery: surgery performed using an endoscope (a small camera) and special surgical tools. Endoscopic surgery usually involves one or more small incisions and a shorter recovery time than traditional open surgery. epinephrine: a hormone secreted by the adrenal glands during conditions of stress. It raises the blood pressure and breathing rate, and constricts blood vessels. expander implant: a temporary breast implant that is slowly inflated with saline to stretch the tissue in preparation for a permanent breast implant. F fascia: a sheet of connective tissue that covers or binds muscles or organs. fibrous tissue: tissue containing tightly woven strands of collagen protein. fluffing: a condition that occurs when the breast implants drop into a slightly lower, more natural position, after the skin and muscle have completely relaxed during healing. Also called dropping. form stable: Another name for highly cohesive or gummy bear breast implants. Form stable breast implants are filled with viscous gel that won’t migrate in the event of a rupture. G general anesthesia: a type of anesthesia often used for breast augmentation. Under general anesthesia, you are fully asleep. glandular: relating to or involving glands, gland cells, or their products. gummy bear implants: nickname for a type of breast implants filled with highly cohesive silicone gel. This viscous filler has the consistency of a gummy bear, so if the implant ruptures, the gel won’t migrate. H hematoma: a break in a blood vessel, causing a blood clot or localized, blood-filled area. hemorrhage: an abnormal flow of blood from an incision or wound. hypoxia: lack of oxygen to the body. I inferior: lower or closer to the feet. inframammary crease: the crease below the breasts where the breast envelope meets the skin over the rib cage. inframammary incision: an incision in the inframammary crease used to place breast implants. Also called the “crease” or “fold” incision. intercostal arteries: the arteries responsible for the blood supply to the breast. intracapsular rupture: type of implant rupture in which a silicone-filled breast implant breaks, but the silicone is contained within the capsule. intravenous sedation: sedation or anesthesia delivered through an intravenous (IV) line. L lactation: producing milk from the breasts. latissimus dorsi flap reconstruction procedure: a reconstructive procedure that uses the latissimus dorsi (a back muscle) to form a breast mound. lobules: the part of the breast where milk is produced. The lobules are gathered into lobes. There may be as many as 20 lobes per breast. local anesthesia: anesthesia that numbs a small part of the body. lidocaine: a local anesthetic, also called Xylocaine. lumpectomy: surgical removal of breast tumor tissue. lymph node: any of the small glands that make up the lymphatic system, which carries lymph fluid, nutrients and waste material between the body tissues and the bloodstream. The lymphatic system is a major component of the body’s immune system. lymphadenopathy: abnormal enlargement of the lymph nodes. lymphedema: swelling, generally in the arms or legs, that occurs when there is a blockage in the lymphatic system that is preventing lymph fluid from draining well. This tends to occur after certain types of breast cancer surgery. M malposition: incorrect or abnormal position. mamma: breast, organ of lactation; plural: mammae. mammogram: a breast X-ray. mammography: the use of X-rays to form a diagnostic picture of the breast. mastectomy: surgical removal of the breast or breasts and associated tissue. mastopexy: breast lift. micromastia: abnormal smallness of the breasts. myectomy: excision of muscle. N nipple: the bulge of pigmented, erectile tissue in the center of the surface of the breast from which milk can flow. O P pectoralis major: either of two large, fan-shaped chest muscles. These are the muscles that a breast implant is placed beneath in submuscular or subpectoral placement. pectoralis minor: the small chest muscles. These muscles are targeted with a Botox breast lift. periareolar: surrounding the areolae complex of the nipple. pocket: a cavity made in the body by dissection. In breast augmentation, the pocket is the space created for the implant. pole: the upper or lower half of the breast or breast implant. ptosis: sagging. R regional anesthesia: anesthesia that numbs a region of the body. This type of anesthesia is not routinely used for breast augmentation. rectus abdominus fascia: the fascia covering the rectus abdominus muscle of the abdomen. It is used to help cover the breast implant in full submuscular implant coverage. rippling: the appearance of ridges or wrinkles in a breast implant. S saline: salt water. saline-filled implants: a type of breast implant that is filled with sterile saline. sedation: a state of calm or sleep. seroma: a collection of fluid under the skin. serratus muscle: a muscle on either side of the chest that is connected to, and covers, the ribs. It is used in conjunction with the pectoralis major muscle and rectus abdominus fascia in full submuscular breast implant placement. silicone: the second most abundant element on Earth and a staple ingredient in commercial products, from pacifiers and breast implants to non-stick bakeware and adhesives. silicone-filled implants: breast implants filled with silicone gel. sternum: the breast bone between the two breasts. submuscular, full submuscular: implant placement patterns. Full submuscular placement involves placing the implant entirely under the muscle. supine: face up. symmastia: condition characterized by touching, in the center of the chest, of the two breast implants; also called kissing implants and “uniboob.” symmetrical: similar in size and shape. T tachycardia: a rapid heart rate. thoracic: relating to or located within the thorax or chest. thromboembolus: obstruction of a blood vessel by a blood clot; plural, thromboemboli. thrombosis: localized coagulation of blood. transaxillary: though the axilla (armpit). transverse: lying or going across at an angle. transumbilical breast augmentation (TUBA): a procedure in which breast implants are inserted via the belly button. tubular (or tuberous) breasts: a breast shape caused by a small breast base and/or herniated areolae. twilight sedation: a light form of sedation anesthesia that provides full sedation, but you can be roused. U umbilical: relating to the navel or belly button. V vasoconstrictor: a drug that constricts the blood vessels. G C H A P T E R 54 The dual plane approach to breast augmentation Steven Teitelbaum History The breast implant pocket choice has a profound effect on the appearance of the augmented breast. Along with the selection of the device itself, it is the most important preoperative decision. Critical manifestations of this choice may not be apparent for many years, as some effects of the implant on the soft tissue occur gradually yet inexorably. The most commonly described pocket locations are: (1) total submuscular (subserratus and subpectoral); (2) partial retropectoral (behind the pectoralis with its origins from the ribs left intact); (3) subfascial (between the pectoralis muscle fascia and the pectoralis muscle); (4) submammary or subglandular (between the breast and the pectoralis fascia). Total submuscular is more frequently a reconstructive technique, less commonly done for augmentation owing to a more painful and bloody dissection, a tendency for the device to rise superiorly, and diffi culty in predictably creating a deep and well-formed inframammary fold. Subfascial has not been widely adopted due to an absence of satisfactorily controlled or long-term data. With scarcely 0.5 – 1 mm more coverage than a classic submammary dissection, this procedure is only a minor variation of the submammary pocket and does not qualify as a distinct pocket type. Partial retropectoral and submammary are the most popular methods. Proponents of each are quick to point out the distinct advantages of their technique and the disadvantages of the other. These comments are frequently appropriate. But these comments are not equally applicable to all situations. There are indeed breast types for which the benefi ts and drawbacks of one pocket makes it the better choice. Even so, some shortcomings of that preferred pocket frequently remain at issue. The dual plane as fi rst published by John Tebbetts in 2001 is the ideal compromise, in that it allows the implant to be simultaneously retropectoral where the device most needs coverage, and retromammary where it most needs to be in direct apposition to the breast. This allows near-total achievement of the purported benefi ts of both at the same time, while minimizing the trade-offs associated with selecting just one of the two pockets. It is therefore less of a compromise per se, than a way of “ having your cake and eating it, too ” , essentially doing both pockets at once, using each pocket where it exacts its greatest benefi t. While submammary and partial retropectoral are “ pure ” extremes, the dual plane is a continuous spectrum of options, occupying the “ gray-zone ” in between. The operation starts with the creation of a partial retropectoral pocket. The origins are carefully divided along the inframammary fold, which allows the cut edge of the muscle to glide a bit superiorly, so that there is both a small submammary and a large subpectoral area of the pocket, and hence the term dual plane. By disrupting attachments of the muscle to the overlying gland, the muscle can be gradually and incrementally raised, thereby reducing the proportion of subpectoral pocket and increasing the proportion of submammary pocket. The purported advantages of the partial retropectoral pocket are predominantly coverage along the sternum and over the superior border of the implant; the dual plane preserves these. The purported advantages of the submammary pocket are to direct implant pressure upon the lower pole; the dual plane preserves these as well ( Fig. 54.1 ). Criteria for the ideal pocket Our ability to determine the ideal pocket for a given situation rests upon the criteria that we choose to use to make that determination. Rather than vague, subjective decisions that allow certain issues to be overemphasized and others neglected, it is important to attempt to quantify all of the pertinent issues and measure each of the methods against them. Over the last several decades, published reoperation rates in PMA studies have not changed despite the use of different implants, remaining consistently at about 20% at three years. In a study of one device, a single surgeon achieved a 0% 675 Section 11: The breast Go to www.expertconsult.com to see updates to this chapter 0060_ch54_9780702031687.indd 675 4/8/2009 3:33:26 PM G Section 11: The breast Aesthetic Plastic Surgery 676 deforming and even uncorrectable. It is therefore not enough just to tally complications, but also to consider their severity. Dual plane data objectively show that this procedure succeeds in maintaining the advantages of both pockets while mitigating the trade-offs associated with selecting a single pocket. Preservation of future options in the event of an unsatisfactory outcome is important: if Plan A was still a viable option after Plan B, but Plan B would not be after Plan A, then that would suggest an advantage for starting with Plan B. Finally, outcomes need to be assessed at long intervals after surgery. Irrevocable, permanent, progressive, and at times totally uncorrectable changes occur to a breast years after an augmentation. Adequacy of tissue coverage needs to be judged at the longest possible intervals, decades if possible. Such long-term data is meager, but owing to the importance of such lifelong changes on the breast, at this point anecdote and extrapolation of shorter-term results should be considered ( Fig. 54.3 ; Table 54.1 ). breast augmentation dubai breast enlargement dubai breast implants dubai breast surgery dubai non surgical breast augmentation dubai breast surgery in uae boob job dubai Pain and recovery In general, there is less pain with the submammary approach, as the submuscular approach subjects the sensitive rib cage to possible trauma and the overlying muscle to stretching. But the largest data ever assembled on postoperative pain showed that 24-hour recovery without the use of any narcotics or pain pumps could be routinely achieved with a dual plane approach. Bloodless surgery and avoidance of creating any rib trauma circumvented the typical pain experienced from the rib cage in submuscular patients. Precise, gentle elevation, bloodless elevation of a pectoralis muscle paralyzed by the anesthesiologist results in a minimum of trauma to the muscle. This author has routinely been using these techniques for many years, and only uses ibuprofen for postoperative pain for routine augmentation mammaplasty in all planes, including the dual plane. Dual plane patients routinely go out to dinner, shower, and wash and brush their own hair the night of surgery. They describe the feeling as “ tight ” , a “ pressure ” , “ soreness ” , or “ like working out hard ” . Fig. 54.1 The three types of dual plane breast augmentation. A , Dual Plane Type I. B , Dual Plane Type II. C Dual Plane type III. A B Complete division along IMF C No division No division No divisionbreast augmentation dubai breast enlargement dubai breast implants dubai breast surgery dubai non surgical breast augmentation dubai breast surgery in uae boob job dubaiFig. 54.2 Retromuscular pockets are often criticized for causing high-riding implants. In this case, the dissection was a blunt/blind transaxillary augmentation. The muscle was divided along the IMF on the left, but not the right. This is not a shortcoming of the procedure itself, but from its execution in this particular instance. 3-year reoperation rate in contrast to an average of 13.9% for all the doctors in the study. Taken together, these two fi ndings demonstrate that the outcome in breast augmentation is determined far less by the type of the device than by other factors ( Fig. 54.2 ). In the absence of data, surgeons must turn to the anecdotal. But when data is available, it trumps anecdote. Of all endpoints, the most decisive measurement of outcome is the reoperation rate, as it is an incontrovertible endpoint. “ Satisfi ed ” or “ happy ” patients are imprecise and unquantifi able endpoints, and since we have all seen unhappy patients with beautiful results and thrilled patients despite notable problems, they do not qualify as adequate endpoints with which to entirely judge the quality of an operation. The absolute incidence of reoperation tells only part of the story: the severity of a problem must also be considered. Some may be minor or annoying, while others may be 0060_ch54_9780702031687.indd 676 4/8/2009 3:33:26 PM G Chapter 54 The dual plane approach to breast augmentation 677 Fig. 54.3 A & C , Preoperative. B & D , Postoperative. Anecdotes are anecdotal, but sometimes that is the best that we have. If anyone doubts the importance of muscle coverage, they should be shown a series of patients with tissue so thin, with a saline implant looking like this, 11 years after surgery, free from capsular contracture, visible edges or rippling. Cases like this abound, but there are few examples of submammary or subfascial patients at this interval that look this good. A B C D When these same techniques are applied to the submammary approach, patients typically feel slightly less stiff and sore than do dual plane patients, but both groups still consistently achieve a “ 24-hour ” recovery. Any difference is subtle, noted only for a day or two, and is of no real consequence, particularly relative to advantages of achieving more muscle coverage. Coverage and stretch Soft tissue coverage is the single-most important issue affecting the short and long-term result after a breast augmentation. With adequate coverage, the implant edges are less visible, and the breast looks more natural and less augmented. Any folds or irregularities with the implant shell are more concealed. With more tissue over it, the device is less palpable. With less tissue coverage, the edges of the implant are more visible, the breast looks more augmented, and it is easier to feel the implant ( Fig. 54.4 ). Over the long term, these changes become more profound. Implants put pressure on the breast, and the parenchyma gradually compresses and atrophies. The presence of the implant stretches and thins skin. This occurs with implants in all positions. No study will ever randomize patients of similar tissue types and implant sizes and follow them over enough time for a scientifi c conclusion to be made. But a large amount of clinical observation and logic (see Fig. 54.3 and Fig. 54.5 ) offers us guidance. Examples of submammary patients with severe parenchymal atrophy abound, while retropectoral patients with similar characteristics are rarely seen. And when they are, though the implants may have ostensibly been placed “ behind the muscle ” , secondary surgery frequently reveals that the muscle has been avulsed off both the inframammary fold and sternum, thereby sacrifi cing the critical coverage of which we are speaking ( Fig. 54.6 ). These problems are sometimes noticeable within a year or two, but can often take years more to develop. We must be 0060_ch54_9780702031687.indd 677 4/8/2009 3:33:28 PM G Section 11: The breast Aesthetic Plastic Surgery 678 Table 54.1 Pocket comparisons Issue Advantage PRP Advantage subglandular Dual plane remedies Less pain X Best data to date Better coverage X Large advantage vs. SM; difference relative to PRP dependent upon release and up to determination of surgeon Access to lower pole parenchyma X Yes Expands constricted breasts X Yes Fills ptotic breasts X Yes Avoids muscle animation X Rarely clinically signifi cant Reduces tendency to “ ride high ” X Yes Reduces tendency to “ lateralize ” X Yes Faster recovery X Best data to date Less capsular contracture X Best data to date Better for mammograms X Appears to be Reduce parenchymal atrophy X Best data to date Reduces stretch deformities Best data to date Narrower cleavage X No – but subglandular can only do so at the expense of coverage Fig. 54.4 Tissue coverage is always a priority, particularly superiorly and medially. The implant she holds in her hand mimics what is occurring within her breast. With muscle coverage in the upper pole, such a deformity will rarely if ever occur. Fig. 54.5 This is not a capsular contracture. This is a submammary implant. The breast is soft. The patient chose this at the surgeon ’ s behest in order to avoid animation deformity. But even in repose, the signifi cant deformity is present; there is no substitute for soft tissue coverage. aware of these problems and remind ourselves that we need to create a result that will look good not just for years, but for decades. As someone who sees many secondary problems, I can state categorically that subglandular patients present more frequently, with more severe problems, and with more unsolvable problems than do subpectoral or dual plane patients. Such tissue thinning with submammary patients also is a set up for a problem which is diffi cult to correct, as to do so often requires a switch to the partial retropectoral or dual plane position. But once there is a subglandular pocket, the coverage in the retropectoral pocket is forever impaired. Though one can use sutures to tack the muscle back up to the gland, its caudal cut edge can never be retained as caudally as it might have been were this not to have happened, thereby forever impairing inferior coverage. Marionette pullout sutures have been described to hold down the muscle in this situation, but this also cannot achieve the same degree of 0060_ch54_9780702031687.indd 678 4/8/2009 3:33:31 PM G Chapter 54 The dual plane approach to breast augmentation 679 Fig. 54.6 This patient just had removal of subpectoral implants. The dotted line indicates the caudal border of the pectoralis. Though she had “ retromuscular ” pockets, the implant itself had negligible if any coverage as the muscle was so high it could cover only a bit of the implant, and the pressure of it probably pushed the implant away. Though her muscle was still attached to the sternum, the muscle had been inadvertently detached from the overlying parenchyma, thereby allowing it to window shade up far higher than would be ideal even for a DP III. Fig. 54.7 This patient had a submammary capsulectomy and then had a submuscular pocket dissected. It illustrates the basic principle of the DP approach. With no attachment of the muscle to the overlying parenchyma, this muscle window shades strongly superiorly. The DP approach recognizes the importance of maintaining those attachments when it is important to keep the muscle inferiorly to maintain coverage, and emphasizes the importance of a gradual and incremental release of them to allow controlled vertical elevation of the muscle and exposure of the parenchyma in the lower breast when the situation demands. Fig. 54.8 The most common argument for submammary placement is to deal with the postpartum involution and ptosis patient who does not want mastopexy scars. But this group has the thinnest tissue and is the most prone to stretch and thinning. A , A patient merely two years following such a procedure; note the extreme parenchymal atrophy and skin thinning. B , Note the improvement still noted two years after conversion to a dual plane. A B coverage as if the attachments between the muscle and the overlying gland were never disrupted ( Fig. 54.7 ). In conjunction with the thinning, there is often progressive stretch of the skin envelope, sometimes necessitating mastopexy. Even if this mastopexy would have been inevitable in the future with a partial retropectoral or dual plane pocket, such patients frequently have soft tissue thinning or capsular contractures in addition to the stretched skin. This necessitates a pocket change and possible capsulectomy in addition to the mastopexy, which can be a riskier procedure than if the implant had started out dual plane or partial retropectoral. This combination of secondary revision occurs so frequently that efforts must be made at the time of the original surgery so that this doesn ’ t happen ( Fig. 54.8 ; also see Fig. 54.5 ). If tissue coverage is adequate, it almost doesn ’ t matter what is going on with the implant; a capsular contracture may be less noticeable; suboptimal implant shape may be less problematic; implant folds might be harder to discern. These are powerful reasons to select the partial retropectoral pocket over the submammary pocket. But what should one do if there is glandular ptosis or a constricted lower pole and the tissue is thin? Partial retropectoral is preferred for the tissue coverage issue, but submammary may be necessary to allow better expansion of the lower pole. The dual plane solves this dilemma by allowing the upper and inner portion of the implant to be covered by muscle, while the inferior portion, the part that needs to push directly on the gland to expand and fi ll it, can be allowed to be in direct apposition. Achieving “ adequate ” coverage is an insuffi cient goal. “ Maximum ” coverage must be the goal. There is almost no long-term problem that is not solvable when substantial soft tissue is available, and there are few problems completely correctable when soft tissue is not available. There is some sacrifi ce in coverage with the dual plane relative to partial retropectoral, and if tissue coverage in the lower pole is such that the benefi ts of changing to the dual plane do not outweigh its advantages, then it is suggested to patients to have a partial retropectoral pocket. In any case, the reduction in coverage with the dual 0060_ch54_9780702031687.indd 679 4/8/2009 3:33:33 PM G Section 11: The breast Aesthetic Plastic Surgery 680 plane relative to partial retropectoral is reasoned and controlled. Access to parenchyma The most profound advantage of submammary over partial retropectoral is attributable to the direct pressure the implant can make against the gland. This can make it look less empty, and the pressure can better expand a tight lower pole. If behind the muscle, the muscle essentially protects the preexisting confi guration of the lower pole, inhibiting the implant ’ s ability to push it and fi ll it out. And if weak fi brous connections between the pectoralis muscle and breast gland allow the gland to slipe relative to the muscle, placing the implant against the breast tissue can help reduce the extent of inferior tissue migration. Otherwise, the subpectoral placement still allows the gland to slide inferiorly relative to the muscle ( Figs 54.9 and 54.10 ). Depending upon the degree of release with the dual plane, these advantages of the submammary approach can be almost completely if not completely realized with the dual plane approach. The coverage that is preserved superiorly and medially typically allows for muscle coverage where it is most needed: superiorly and along the medial sternal border. Capsular contracture Capsular contracture still remains the leading cause of reoperation in PMA studies, yet publications using antibiotic irrigation and the dual plane pocket have resulted in some of the lowest reported capsular contracture rates to date. Whether it is specifi cally due to the dual plane per se or other factors, such as the irrigation, is not entirely clear. But it is suffi cient to say that the lowest reported capsular contracture rates are with the dual plane position, and no paper suggests an advantage to partial retropectoral over dual plane. Dual plane is the ideal choice. Mammography Given the cancer prone nature of the breast, optimizing the ability to detect cancer early must remain a priority. Numer- Fig. 54.9 The long term stability of the outcome in this post partum atrophy/ptosis patient with implants in the dual plane position demonstrates the value of proper implant sizing and tissue coverage. pre 5 months 1 yr 2 yrs 3 yrs 5 yrs 0060_ch54_9780702031687.indd 680 4/8/2009 3:33:37 PM G Chapter 54 The dual plane approach to breast augmentation 681 ous authors have suggested an advantage to retropectoral over submammary placement for this regard, but it is unclear whether the advantage is directly due to the anatomic location relative the muscle itself, or due to a lower capsular contracture rate below the muscle. Suffi ce to say, mammogram is impaired when the breast tissue cannot be pulled out and away from the implant and placed between the mammogram plates, such as when the implant is hard, there is a large implant relative to the breast tissue, or any other reason that restricts the pull of the tissue forward. While no studies have specifi cally compared sensitivity of mammogram between these pockets over a long period of time, the low incidence of capsular contractures and the extensive muscular coverage over a dual plane implant suggests that this would not be a problem. In any case, the role of MRI in screening for breast cancer is increasing, even for women without breast implants. And since implants do not affect its sensitivity, this entire issue may soon be moot. Muscle animation breast augmentation dubai breast enlargement dubai breast implants dubai breast surgery dubai non surgical breast augmentation dubai breast surgery in uae boob job dubai The lack of signifi cant implant motion or distortion with contraction of the pectoralis is a signifi cant advantage of the submammary position relative to the partial retropectoral pocket. But it is not enough to look at the problematic subpectoral patients with animation problems: one must also be aware of the submammary patients with signifi cant implant visibility even in repose. The deformity of a thin patient with subglandular implants at rest is typically more profound than a partial retropectoral patient during maximal contracture. With the dual plane approach, the release of the pectoralis along the inframammary fold (IMF) reduces if not totally eliminates the forces that might distract the implant superiorly. While the medial origins along the sternum may compress and slightly lateralize the implant on strong contraction, they rarely cause a signifi cant deformity ( Fig. 54.11 ). Fig. 54.10 The constricted lower pole breast is frequently touted as being a reason for submammary, as it allows scoring of the lower pole. In this case, shown here at 5 years post-surgery, a DP II was done, allowing the muscle to rise to the lower border of the areola. This exposed parenchyma for the entire lower pole of the breast, allowing it to be shaped just as much as it would have been were this to have been a submammary placement, but with maintenance of muscle coverage superiorly and medially, which helps to obscure the borders of the implant. 0060_ch54_9780702031687.indd 681 4/8/2009 3:33:39 PM G Section 11: The breast Aesthetic Plastic Surgery 682 Certainly, there is some motion, but in the Tebbetts series, there was no revision requested for this reason. In my experience, there has been occasional complaint and discussion of revision, but I have not switched my own patient to a submammary pocket for this reason ( Fig. 54.12 ). Usually, the patients with any such problems are very thin, and were therefore the least well suited for a submammary pocket. The key in minimizing animation with the dual plane pocket is to uniformly and accurately take the muscle down along the inframammary fold, stopping evenly on both sides at the point at which the IMF meets the sternum, and never releasing along the sternum. It appears that when the IMF is horizontal and meets the sternum at a discrete point, these issues are less problematic than when the IMF curves sharply superiorly as it moves towards the sternum, oftentimes not actually meeting the sternum until being at or even above the level of the nipple. These patients are also often thin, and they represent a particular challenge, in that there in fact may be no way to avoid some deformity with either approach. Fig. 54.11 A critical step of all dual planes – I, II, and III – is to completely divide the pectoralis major along the inframmary fold, stopping at the sternum, without division along the sternum. Failure to divide the origins along the IMF result in either a high-riding implant, superior malposition with animation, or a blunted IMF. However, if tissue coverage is thin ( < 5 mm), they probably should not be divided, as maintaining coverage is the fi rst priority. Division along the sternum can result in symmastia, excessive edge visibility and uncorrectable deformities. Complete division along IMF No division Fig. 54.12 DP and all retromuscular pockets are criticized for animation deformities. But the patient needs to be considered in repose as well. Here the same patient on the top is seen submammary, relaxed in two different poses. Though there is no animation deformity, the implants are unattractive. In the lower left, she is shown relaxed in the DP position, looking much prettier and more natural. In the lower right, she does demonstrate distortion with contracture, but no doubt even if this is the maximal distortion she can manage, it is still less deformed than she looks in either of the preoperative views in repose. 0060_ch54_9780702031687.indd 682 4/8/2009 3:33:44 PM G Chapter 54 The dual plane approach to breast augmentation 683 No matter which pocket is selected, the patient must be fully informed preoperatively of the trade-offs, and participate in the pocket selection. That way, if she has an animation deformity or implant deformity later, she can be reminded that she preferred accepting that problem to the risks of the other pocket. If a patient is not made aware of these choices preoperatively, then dissatisfaction and request for revision remain avoidable risks for revision. Narrower cleavage Both partial retropectoral and dual plane procedures accept the inner border of the pectoralis major muscle as an absolute limit to the medial placement of the implants. Once submammary, the implant can certainly be more medial. However, this comes at a price: the patients who most request or “ need ” such medialization invariably have the least soft tissue cover, and moving the implant medial to where the internal border of the pectoralis origin on the sternum results in risking symmastia and excessively visible implant edges. It is foolhardy to attempt to create cleavage by excessive medial placement of any implant, as tight skin usually pushes the implant laterally and the thin skin results in distinctly visible edges. So while the submammary does have the potential to place implants more medially, this amounts to more of a liability than an advantage. Physical evaluation Until experienced, most surgeons believe that an operation is all about what happens the day of surgery. In fact, it is the decisions that lead up to surgery that often have the most long-term effects on a result. This is particularly true of breast augmentation, where patient wishes, patient anatomy, and surgeon judgment converge. This topic is more important than pocket choice or any other issue with breast augmentation alone. The following are the most important of these points: Patient education The patient must be informed about the limitations of her tissue, so that her expectations are met. She must anticipate all trade-offs with respect to issues such as tissue coverage, animation, correction of ptosis, etc. When patients participate in these choices and sign off on them, the incidence of revision surgery is reduced and patient satisfaction increases. Determination of ideal implant size A patient is asked to decide whether she wants an implant that fi ts properly within her tissue, or she wants to force a certain size into her breasts without regard for creating an unnatural result in the short term and causing permanent tissue changes in the long term. Informed patients will usually select the latter. In that case, using the base width, skin stretch, and degree of envelope fi ll, the ideal implant size for that patient ’ s breast is determined. Larger will have an upper convexity and look more full, stuffed, or fake. Smaller will have a concave upper pole and look emptier. Determination of need for coverage and for muscle release breast augmentation dubai breast enlargement dubai breast implants dubai breast surgery dubai non surgical breast augmentation dubai breast surgery in uae boob job dubai The dual plane preserves coverage and allowing coverage where it is needed. These two opposing characteristics need to be evaluated in all patients. Coverage It is always a goal to maintain as much coverage as possible, sacrifi cing coverage only when there is a reason to do so. With the exception of patient request (after being fully informed), a dual-plane approach is suggested to all. If coverage is < 2 cm of pinch at the upper pole, then a submammary approach will not even be offered. If pinch < 5 mm at the IMF, serious consideration is given to not releasing the muscle to create the dual plane, choosing instead to use a partial retropectoral pocket. In such situations, the long-term benefi ts of preserving maximal coverage often outweigh animation deformities, widening of the intermammary distance, and the predictability and crispness of the inframammary fold position. Muscle release The breast is examined for lower pole constriction or glandular ptosis that might necessitate controlled release of the muscle from the gland. While one might decide specifi cally preoperatively to perform a dual plane type II or type III, the surgeon should always start by dissection a type I, and then examine and feel the breast, releasing as much as is necessary during the operation. Need for mastopexy Many patients see plastic surgeons for a breast augmentation following lactation or weight loss. For some of these women, mastopexy is the appropriate procedure. Not wanting scars, some of these patients either receive an implant that fi lls, but is larger than they wish, or an implant of the size they want but which creates inadequate fi ll. In either case, and in particular in the case of the larger implants, the result is aesthetically compromised, and the already stretched skin stretches more and deteriorates with time. I have seen many such patients who had received submammary augmentations, and have tried this on my own patients. If followed long enough, the results are frequently unsatisfactory. Neither is the dual plan an answer for these patients; if the nipple (N) is below the fold, if N : IMF distance is > 9.5 cm on maximum stretch, or if substantial parenchyma lays caudal to the inframammary fold, mastopexy must be considered, and augmentation should either not be attempted or only performed on the patient who clearly demonstrates an understanding of the limitations of such a procedure (see Fig. 54.8 ). Anatomy The pectoralis major muscle has origins along the clavicle, sternum, and the 4th – 6th ribs along the IMF, and inserts onto the humerus, causing fl exion and internal rotation. Studies 0060_ch54_9780702031687.indd 683 4/8/2009 3:33:48 PM G Section 11: The breast Aesthetic Plastic Surgery 684 have demonstrated that the pectoralis origins along the IMF can be released without loss of strength or coordination. What is most relevant to the dual plane is the recognition that the deep surface of the pectoralis glides over the chest wall. It is anchored like a trampoline on three sides to the humerus, clavicle, and ribs. Like a trampoline released on one edge, the muscle will retract strongly away from the side of the release. The only thing that holds it in place – in distinct contrast to its deep surface – is that its superfi cial surface is tightly bound to the deep surface of the gland. The superfi cial surface of the muscle gives rise to the Cooper ’ s ligaments and fi brous tissue that ramify throughout the breast. These attachments help hold the caudal edge of the muscle inferiorly, thereby maintaining coverage to the lower pole of the implant. Following careful release of the muscle along the inframammary fold, the surgeon will observe the muscle “ window shade ” , sliding superiorly 1 – 2 cm. However, if there was an inadvertent dissection on the superfi cial surface of the muscle, thereby disrupting some of the fi bers connecting the muscle to the overlying gland, the muscle will window shade far more, sacrifi cing what might be intended coverage of the lower pole. This point is most emphasized when creating a retropectoral pocket following a submammary capsulectomy. Even if the pectoralis origins along the IMF are left intact, the caudal edge of the muscle window shades very high superiorly; if those origins are released, it may move so high that it cannot even cover the implant at all. Understanding this dynamic is critical to the dual plane approach. Technical steps See Table 54.2 ; see also Fig. 54.1 . Though a dual plane dissection can be done from all incisions, the inframammary incision allows the greatest degree of visualization and control of the dual plane pocket. Most specifi cally, it allows preservation of all the attachments between the muscle and the overlying gland, so that if they need to be dissected, it can be done in a specifi c and controlled manner. Dissection from the periareolar incision down to the inframammary fold or the proposed level of transection of the muscle invariably results in some degree of inadvertent disconnection of the muscle from the overlying gland, thereby resulting in unintentional superior elevation of the muscle, creating for example a dual plane type II or III when a type I was the goal. I frequently perform revision surgery on patients who had periareolar augmentation in which the operative note described the procedure as “ partial retropectoral ” and described only division of the muscle along the inframammary fold, yet the caudal edge of the muscle is frequently found well above the upper border of the areola, beyond what is even considered a dual plane III. This may be due to a combination of a bit of release of the muscle along the sternum, but it seems more commonly due to a release of the attachments of the superfi cial surface of the muscle from the gland simply as part of the tunneling process to reach the inframammary fold. Unless a DP II or III is a goal, a surgeon should probably perform dual plane pocket surgery from the inframammary incision until they have gained substantial experience. Many surgeons divide the muscle along the inframammary fold and describe the procedure as “ half over – half under ” , or even “ partial retropectoral ” , which is exactly what is described as a dual plane type I. Whatever the label, these surgeons should always be cognizant that the loss of tissue coverage from a periareolar incision is always a risk unless extremely fastidious dissection is done. Table 54.2 Technical steps Description Indication Goal Partial retropectoral Pectoralis attached to sternum and to IMF IMF pinch < 5 mm Maintain maximum coverage Dual plane type I Same plus complete division of pectoralis along IMF All parenchyma above IMF; gland adherent to muscle; A : IMF on maximum stretch 4 – 6 cm Small sacrifi ce in coverage to increase IMF accuracy; reduce animation deformity; allow implant to sit at bottom of pocket Dual plane type II Same plus pectoralis released from overlying gland and allowed to slide to about the lower border of the areola Most parenchyma above IMF; looser attachments of gland to muscle with some sliding of gland over muscle; stretched lower pole skin with A : IMF under maximum stretch 5.5 – 6.5 cm More sacrifi ce in lower pole muscle coverage in order to reduce risk of mobile parenchyma from sliding off of muscle, better fi ll of loose envelope Dual plane type III Same plus greater release of pectoralis from gland, allowing it to slide to about the upper border of the areola Ptosis with one-third or more of parenchyma below level of anticipated IMF with patient standing; substantial sliding of gland over muscle; more stretched lower pole skin with A : IMF under max stretch 7 – 8 cm or constricted lower pole breasts Most sacrifi ce in lower pole muscle coverage to allow maximal contact of implant against gland; allows for maximal scoring/reshaping of gland to allow maximal expansion 0060_ch54_9780702031687.indd 684 4/8/2009 3:33:48 PM G Chapter 54 The dual plane approach to breast augmentation 685 Likewise, a DP I, involving only the release of the pectoralis along the inframammary fold, can be undertaken from the transaxillary incision. Unlike a blunt and blind transaxillary approach which risks uneven release of the muscle and imprecise level of the inframammary fold, a true DP I transaxillary should be done with a bloodless, endoscopic technique. Creating a DPII or III, however, involves retrograde dissection from the transaxillary incision. This remains on the technical fringe at this time, and should be undertaken by surgeons experienced with endoscopic transaxillary partial retropectoral pocket creation after experience with the dual plane for a variety of situations from the inframammary incision. IMF approach See Fig. 54.13 . The fi rst step is to determine the ideal position of the inframammary fold. It is calculated from the nipple with the tissue placed on maximum stretch. In general, the standard of 7 cm for a base width of 11 cm, 8 cm for a base width of 12 cm, and 9 cm for a base width of 13 cm holds true. If the inframammary fold is already at that height, it does not need to be altered. An incision is made at the proposed inframammary fold. Dissection is carried straight down to the muscle fascia with the electrocautery, taking care not to skive inferiorly. There is a natural tendency of the cut edge of the tissue to pull inferiorly, so the dissection may angle superiorly, but only for the purpose of not undercutting the skin edge and inadvertently lowering the fold more than intended, if at all. The fascia is scored carefully with the cautery, so that the muscle is visible. Place in a double-ended or army-navy retractor with the tip pointed towards the medial border of the areola. With no horizontal dissection yet made, there will be little to hold the tissue up onto the blade of the retractor, so use the ulnar fi ngers of the retractor holding hand to pull the tissue onto the blade. Lift up towards the ceiling. Only the pectoralis will tent up. If the muscle does not tent at this point, it may be that the muscle is tight, or it may be that it is not the pectoralis. To ensure that it is pectoralis, and neither serratus, rectus, nor intercostals, touching it with the cautery will make the pectoralis in the upper chest contract. If still not clear, only then dissect just a couple of millimeters along the muscle surface in a cephalad direction. These are the important fi bers that you want to preserve in order to hold the muscle down after you release along the inframammary fold, so sacrifi ce no more than necessary for the anatomy to be clear. This will allow you to see the fi bers of the muscle, and allow some tissue to lie over the blade of the retractor, thereby allowing the pectoralis to tent up. Again advance the retractor blade to the edge of the muscle, pointing the blade to the medial border of the areola, pulling the breast tissue onto the retractor, and lifting toward the ceiling. Because it is loose on its deep surface, the pectoralis will tent upwards. Holding your hand down onto the abdomen so that the cautery is horizontal, sweep gently the taught pectoralis fi bers that appear vertical in front of you. Use hand switching monopolar forceps, as it allows precise control of blood vessels by squeezing, but so too can it be held together and used as a Bovie pencil. So long as it tents, it is pectoralis. So long as your cautery is horizontal and parallel to the chest wall, the chest is safe. Keep advancing the retractor forward and lifting up after every stroke of the cautery. With each motion of the cautery and repositioning of the retractor, the muscle will tent higher and the plane through the muscle will become more obvious. With this maneuver, you will very quickly get through the muscle, and will see the subpectoral space. Free up areolar tissue that is immediately in front of the incision, and then turn the retractor blade medially along the inframammary fold towards the sternum. Controlling the tension of the retractor blade on the muscles with fi ngers on the outside of the breast, use the cautery to take down the muscle about 1 cm above the proposed inframammary fold. This may serve as a shelf to help support the implant; it prevents over lowering of the fold; and it allows point coagulation of intramuscular blood vessels. Cut through the muscle and the overlying fascia. This should be bloodless and very easy to visualize. In fact, this dissection is so anatomic, that you should expect to be able to do it without needing to place a single four by eight into the pocket. Look beyond the tissue plane immediately in front of you, anticipating and seeing the perforators ahead of time. Continue all the way to the sternum, but do not proceed up the sternum at all. If you are unclear where this point is, mark it with an “ X ” externally on both sides preoperatively. Continue the dissection sweeping superolaterally, and then sweeping inferiorly. This helps to fi nd the plane between the pectoralis major and pectoralis minor, which are more intertwined if the dissection in that area starts inferolaterally instead of superolaterally. Irrigate with antibiotic solution and inspect the pocket. Take note of the long, narrow V -shaped trough where the muscle was released inferomedially and window shaded a bit superiorly. Inspect where the cut edge of the pectoralis is relative to your incision; sometimes it is just a few millimeters beyond it, and sometimes it is already window-shaded several centimeters. This will vary based upon how cleanly you got through the pectoralis and how tight the given patient ’ s connections between the pectoralis and breast tissue are. Place a fi nger in the incision and feel the lower border of the muscle and lift up, taking note of the position of the muscle through the skin as shown by the position of your fi nger. This inspection process is not just important in order to defi ne what you need to do for that specifi c patient, but done repeatedly, it provides the surgeon with a valuable experience about the dynamics of the muscle and the soft tissue. If the intention is to do a dual plane I, by virtue of the muscle release, the dual plane portion of the dissection is complete. The implant can be placed and the incision closed. If the goal is to do a dual plane type II or type III, then now is the time to do a release. This release is gradual and incremental. It cannot be overstated that substantial differences in position of the caudal edge of the pectoralis are created by just several millimeters of dissection. Surgeons ask 0060_ch54_9780702031687.indd 685 4/8/2009 3:33:48 PM G Section 11: The breast Aesthetic Plastic Surgerybreast augmentation dubai breast enlargement dubai breast implants dubai breast surgery dubai non surgical breast augmentation dubai breast surgery in uae boob job dubaiFig. 54.13 A & B , After the retropectoral pocket is made, the pectoralis is divided 1 cm above the proposed inframammary fold. Note the use of the ulnar digits on the retractor hand pressing the muscle under tension so that it splits as it is divided. The superior and inferior cut edges are visible. When this is divided up to the sternum, a dual plane I will have been created, as shown in this photo. Depending upon the tension of the tissues, the muscle will window shade up a centimeter or two; in this case the muscle is about half the width of the retractor blade above the IMF. C , To go from a dual plane I to a II or III, the fi brous connections between muscle and the overlying parenchyma must be taken down. Just a few sideways swipes with the cautery is enough to cause signifi cant movement of the muscle. D , After just a few swipes of the cautery freeing up some attachments of the muscle to the gland, the muscle moves cephalad. The fresh yellow fat shows the signifi cant motion of the muscle relative to the last photo. Again, note the use of the ulnar digits against the retractor to create tension at the muscle parenchyma border, thereby making the dissection more precise and facile. E , When converting to a DP I to a II or a III, note how the hand and the retractor are used as a unit to create tension at the muscle/parenchyma interface. F , Here the release is being done more laterally. It can be adjusted on each breast exactly as the conditions necessitate. G , Copious irrigations with “ Adams ” solution (50 mL Betadine, 80 mg gentamicin, 1 g Ancef in 500 mL NS) is used throughout the operation. Note the yellow fat visible just beyond retractor; cut edge of muscle is just visible. H , In this case, the muscle is released to the lower border of the areola, which is a so-called dual plane II. When it is released to about the upper border of the areola, it is termed a DP III. A G H E F C D B 0060_ch54_9780702031687.indd 686 4/8/2009 3:33:49 PM G Chapter 54 The dual plane approach to breast augmentation 687 why they can ’ t dissect between the muscle and the gland before the muscle dissection, and the reason is that such small amounts of dissection result in such signifi cant movement of the muscle, that it is impossible to predict where the muscle will end up before dissecting the pocket and releasing the IMF. With the curved end of a double-ended retractor placed in the incision, abutting to the caudal edge of the muscle, but with only breast tissue within it, use the other fi ngers in the retractor hand to push in on the breast, so that together with the retractor, it is putting tension between the muscle and the overlying gland. Visualize the fascial connections between the muscle and gland, and use the cautery to gradually cut these, using sideways sweeping motions. You will see the muscle quickly pull away from the retractor and slide upwards. Once it does this even for several millimeters, move the retractor medially and laterally and repeat this process where you feel there is restriction by the muscle. Rather than repeating this motion in the same area, keep moving around, as this will give the most control over the fi nal position of the muscle. While illustrations suggest dual plane type I, II, and III as distinct entities, they are part of a continuum of options. Their designations are designed as a guide to enable us to think about a clinical situation and compare notes. But in any given patient, the muscle does not necessarily end exactly at the lower border of the areola (type II) or the upper border of the areola (type III). Rather, the release is made to the extent that is necessary to achieve the exposure of the implant to the gland of the breast. The most important point is not to overdo it. You can always release more, but once it is released, it is diffi cult if not impossible to pull the muscle back down. Put your fi nger back in as you did before, and note the chance in position of the muscle relative to before you did the release. Feel all along its edge, and go back and release more where you feel it is necessary. If you feel bands within the breast that are restricting expansion, such as with a constricted lower pole, or when the IMF had to be lowered with a tight IMF, now would be the time to score the lower pole, much as you might have done with a submammary pocket. Irrigate again with antibiotic solution, recheck for bleeding, and place the chosen implant close per the usual routine. Postoperative care With precise visualization of the pocket, no special bras or straps are necessary to try to push the implant into a pocket. Tape or a Steri-strip over the incision is the only dressing that is used. With bloodless dissection, no special bandages are necessary to create compression, and early motion is not just allowed, it is ordered. Patients move their arms over their head in the recovery room in a gradual jumping jack type of motion. They go home, take a nap, and then are instructed to continue their exercises every hour while awake, take a shower, and leave the house for dinner. They may drive a car when they feel that they can safely make unrestricted movements, which is usually in two to four days. They are encouraged to do all normal daily activities that do not involve particular exertion, such as opening and closing car doors, putting on a seatbelt, lifting a baby, emptying a dishwasher, or making dinner. They may return to the gym after three weeks, though some surgeons allow this after two weeks. With gentle, precise, and bloodless dissection, patients are only given narcotics through their time in the recovery room, and are managed over 95% of the time with ibuprofen alone at home. Complications There is no complication of dual plane that has not been well-described with either the submammary or partial retropectoral operations. The issue with dual plane is not that there are new complications, but that the patient and surgeon understand its limitations. So long as these trade-offs are well understood preoperatively, they are accepted later. For instance, in cases of extreme mobility of the breast over the underlying chest wall, inferior sliding of tissue may still occur with the dual plane approach. It is my impression that in extreme cases of laxity this may occur more with the dual plane than the submammary approach, but this is diffi cult to quantify because even the submammary approach does not always totally solve the problem. Though dual plane can reduce muscle animation relative to partial retropectoral, it cannot eliminate it to the same extent as the submammary pocket. Patients need to be aware of this, and make their decision about the pocket they prefer. 0060_ch54_9780702031687.indd 687 4/8/2009 3:33:53 PM G Pearls & pitfalls Pearls • When you have a choice in breast augmentation, always prioritize coverage. This will make the breast more natural in the short term and reduce the likelihood of diffi cult to correct long-term problems. • Point out all limitations a patient ’ s pre-existing anatomy poses on her result preoperatively. This will help her to let you do what you think is best for her, and will prepare her to accept trade-offs and shortcomings in her result later. • With the dual plane, dissect a partial retropectoral pocket fi rst. The more directly you are able to get behind the muscle, the less it will move superiorly after muscle division. • Do not force yourself to choose which type of dual plane you will do; these are not so much distinct entities as points on a path. You should feel the breast during the dissection and adjust the dissection accordingly. • Demand of yourself to make a gentle and bloodless pocket dissection so that your patients have an easy recovery. Pitfalls • The dual plane is not perfect, and though it maximizes most of the advantages and minimizes most of the disadvantages of either the submammary or partial retropectoral pockets, neither the surgeon nor the patient should think that it is perfect. • It is easy to over-dissect the attachments between the muscle and gland; avoid excessive dissection in that plane before dividing the pectoralis along the IMF, and then only release gradually and incrementally. • Do not release the pectoralis ever along the sternum; it creates deformities that are diffi cult to correct. Summary of steps 1. Partial retropectoral: Pectoralis origins left intact along sternum and IMF. 2. Dual plane type I: Pectoralis origins left intact along sternum, but divided along the IMF. 3. Dual plane type II: Same plus pectoralis released from overlying gland and allowed to slide to about the lower border of the areola. 4. Dual plane type III: Same plus greater release of pectoralis from gland, allowing it to slide to about the upper border of the areola. Further reading Adams WP Jr . The process of breast augmentation: Four sequential steps for optimizing outcomes for patients . Plast Reconstr Surg 2008 ; 122 ( 6 ): 1892 – 1900 . Adams WP Jr , Rios JL , Smith SJ . Enhancing patient outcomes in aesthetic and reconstructive breast surgery using triple antibiotic breast irrigation: Six-year prospective clinical study . Plast Reconstr Surg 2006 ; 118 ( 7S ): 46S – 52S . Spear SL , Carter ME , Ganz JC . The correction of capsular contracture by conversion to “ dual-plane ” positioning: Technique and outcomes . Plast Reconstr Surg 2006 ; 118 ( 7S ): 103S – 113S . Tebbetts JB , Adams WP . Five critical decisions in breast augmentation using fi ve measurements in 5 minutes: The high fi ve decision support process . Plast Reconstr Surg 2006 ; 118 ( 7S ): 35S – 45S . Tebbetts JB . Achieving a zero percent reoperation rate at 3 years in a 50-consecutive-case augmentation mammaplasty premarket approval study . Plast Reconstr Surg 2006 ; 118 ( 6 ): 1453 – 1457 . Teitelbaum S . The Inframammary approach to breast augmentation . Clin Plast Surg 2009 ; 36 ( 1 ): 33 – 43 Section 11: The breast Aesthetic Plastic Surgery 688 0060_ch54_9780702031687.indd 688 4/8/2009 3:33:53 PM Please see inside for Indications and Important Safety Information. ART. SCIENCE. A collection as diverse as your patients, Natrelle® is the #1 plastic surgery portfolio.1,2,*,† Shaping the future with you *Based on surgeon survey data, December 2016 (N = 100). †Based on US market share data through November 2016 (N = 67). ART. SCIENCE. Table of contents Indications and Important Safety Information 2 Natrelle®—the most complete portfolio 8 The Natrelle INSPIRA® Collection 13 Natrelle® 410 Anatomical Gel Breast Implants 23 Natrelle® Saline-Filled Breast Implants 31 Natrelle® 133Plus Tissue Expanders 36 Natrelle® 133 Tissue Expanders 41 Natrelle® tissue expander accessories 46 Natrelle® breast implant accessories 47 ConfidencePlus® warranty program 49 Additional information 50 Lee Natrelle INSPIRA® Style SRM-255 Individual results may vary. To order breast-shaping products, please call Customer Care at 1-800-766-0171. 1 Natrelle® Breast Implants Important Information INDICATIONS Natrelle® Breast Implants are indicated for women for the following: • Breast augmentation for women at least 22 years old for silicone- filled implants. Breast augmentation for women at least 18 years old for saline- filled implants. Breast augmentation includes primary breast augmentation to increase breast size, as well as revision surgery to correct or improve the result of a primary breast augmentation surgery. • Breast reconstruction. Breast reconstruction includes primary reconstruction to replace breast tissue that has been removed due to cancer or trauma or that has failed to develop properly due to a severe breast abnormality. Breast reconstruction also includes revision surgery to correct or improve the result of a primary breast reconstruction surgery. IMPORTANT SAFETY INFORMATION CONTRAINDICATIONS Breast implant surgery should not be performed in: • Women with active infection anywhere in their body. • Women with existing cancer or precancer of their breast who have not received adequate treatment for those conditions. • Women who are currently pregnant or nursing. WARNINGS • Breast implants are not lifetime devices or necessarily a one-time surgery. • Avoid damage during surgery: Care should be taken to avoid the use of excessive force and to minimize handling of the implant. Use care when using surgical instruments in proximity with the breast implant. For more information, please see the full Directions for Use. PRECAUTIONS Safety and effectiveness have not been established in patients with the following: • Autoimmune diseases (eg, lupus and scleroderma). • A compromised immune system (eg, currently receiving immunosuppressive therapy). • Planned chemotherapy following breast implant placement. • Planned radiation therapy to the breast following breast implant placement. • Conditions or medications that interfere with wound healing and blood clotting. • Reduced blood supply to breast tissue. • Clinical diagnosis of depression or other mental health disorders, including body dysmorphic disorder and eating disorders. Please discuss any history of mental health disorders prior to surgery. Patients with a diagnosis of depression, or other mental health disorders, should wait until resolution or stabilization of these conditions prior to undergoing breast implantation surgery. ADVERSE EVENTS Key adverse events are reoperation, implant removal with or without replacement, implant rupture with silicone-filled implants, implant deflation with saline-filled implants, and capsular contracture Baker Grade III/IV. Other potential adverse events that may occur with breast implant surgery include: asymmetry, breast pain, breast/skin sensation changes, capsular calcification, delayed wound healing, hematoma, hypertrophic scarring/scarring, implant extrusion, implant malposition, implant palpability/visibility, infection, nipple complications, redness, seroma, swelling, tissue/skin necrosis, wrinkling/rippling. For more information see the full Directions for Use at www.allergan.com/labeling/usa.htm. To report a problem with Natrelle® Breast Implants, please call Allergan at 1-800-433-8871. Natrelle® Breast Implants are available by prescription only. 3 2 breast augmentation dubai breast enlargement dubai breast implants dubai breast surgery dubai non surgical breast augmentation dubai breast surgery in uae boob job dubai Intraoperative Breast Implant Sizers Important Information INDICATIONS The Natrelle ® Silicone Sizer and the Allergan Saline Sizer are indicated for single use only for temporary intra-operative insertion in the surgical pocket to evaluate and assist in determining the final breast implant size/volume. The Natrelle ® Re-sterilizable (410 and Round) Silicone Breast Implant Sizer is used during breast augmentation or reconstruction procedures to assist the surgeon in determining the appropriate size of a breast implant to use. IMPORTANT SAFETY INFORMATION CONTRAINDICATIONS All sizers are contraindicated for use as long-term breast implants or tissue expanders. The Natrelle ® Silicone Sizer and the Allergan Saline Sizer are contraindicated for multiple patient use or multiple sterilizations. WARNINGS Sizers are designed for temporary intra-operative use only and are NOT long-term implants. DO NOT alter, insert or attempt to repair a damaged sizer. DO NOT reuse the Natrelle ® Silicone Sizer or the Allergan Saline Sizer, which are for single use only. The Silicone Sizers may rupture and release silicone gel. Infection, necrosis, hematoma/seroma and pain may occur following any type of surgery. Minute quantities of silicone gel may diffuse through the elastomer envelope. PRECAUTIONS The surgeon must carefully evaluate patient suitability and be knowledgeable about the use of this device. DO NOT expose the sizer to contaminants. Avoid damaging the sizer with surgical instruments (e.g. sharp, blunt or cautery devices). DO NOT attempt to repair damaged products. DO NOT damage the sizer by overhandling, manipulation, or excessive force. Maintain a sterile back-up sizer during surgery. ADVERSE EVENTS Adverse events and/or complications may include sepsis, hemorrhage, thrombosis, bleeding, and/or infection. For more information, please visit www.allergan.com/labeling/usa.htm. To report a problem, please call Allergan at 1-800-433-8871. Intraoperative Breast Implant Sizers are available by prescription only. 4 5 Natrelle® 133Plus and 133 Tissue Expanders With/Without Suture Tabs and With MAGNA-SITE® Injection Sites Important Information INDICATIONS Natrelle® 133Plus and 133 Tissue Expanders are indicated for: • Breast reconstruction following mastectomy. • Treatment of underdeveloped breasts. • Treatment of soft tissue deformities. IMPORTANT SAFETY INFORMATION CONTRAINDICATIONS Natrelle® 133Plus and 133 Tissue Expanders SHOULD NOT be used in patients: • Who already have implanted devices that would be affected by a magnetic field (eg, pacemakers, drug infusion devices, artificial sensing devices). • Whose tissue at the expansion site is determined to be unsuitable. • Who have an active infection or a residual gross tumor at the expansion site. • Undergoing adjuvant radiation therapy. • Whose physiological condition (eg, sensitive over- or underlying anatomy, obesity, smoking, diabetes, autoimmune disease, hypertension, chronic lung or severe cardiovascular disease, or osteogenesis imperfecta) or use of certain drugs (including those that interfere with blood clotting or affect tissue viability) poses an unduly high risk of surgical and/or postoperative complications. • Who are psychologically unsuitable. WARNINGS • DO NOT use Natrelle® 133Plus and 133 Tissue Expanders in patients who already have implanted devices that would be affected by a magnetic field (see Contraindications), because the MAGNA-SITE® integrated injection site contains a strong rare-earth, permanent magnet. Diagnostic testing with Magnetic Resonance Imaging (MRI) is contraindicated in patients with Natrelle® 133Plus and 133 Tissue Expanders in place. • DO NOT alter the tissue expander or use adulterated fill. Fill only with sterile saline for injection as described in INSTRUCTIONS FOR USE. DO NOT expose to contaminants. • DO NOT expand if the pressure will compromise wound healing or vasculature of overlying tissue, or beyond patient or tissue tolerance. Stop filling immediately if tissue damage, wound dehiscence, abnormal skin pallor, erythema, edema, pain, or tenderness are observed. • Active infection anywhere may increase risk of periprosthetic infection. Postoperative infections should be treated aggressively. Unresponsive or necrotizing infection may require premature removal. • Natrelle® 133Plus and 133 Tissue Expanders are temporary, single-use only devices, and are not to be used for permanent implantation or beyond 6 months. Tissue expansion in breast reconstruction typically requires 4 months to 6 months. • When using suturing tabs be careful to avoid piercing the shell. Use a new one if damage occurs. PRECAUTIONS Active infections may need to be treated and resolved before surgery. Allergan relies on the surgeon to know and follow proper surgical procedures and carefully evaluate patient suitability using standard practice and individual experience. Avoid damage to the tissue expander and use a sterile backup in case of damage. Pay careful attention to tissue tolerance and hemostasis during surgery. Expansion should proceed moderately and never beyond patient or tissue tolerance. Avoid contamination in any postoperative procedure. ADVERSE REACTIONS Deflation, tissue damage, infection, extrusion, hematoma/seroma, capsular contracture, premature explantation, displacement, effects on bone, pain, sensation, distortion, inadequate tissue flap, and inflammatory reaction. For more information, please visit www.allergan.com/labeling/usa.htm. To report a problem with Natrelle®, please call Allergan at 1-800-433-8871. Natrelle® 133Plus and 133 Tissue Expanders are available by prescription only. 6 7 Artistry becomes reality with the most complete portfolio.3-5 Countless possibilities.6,‡ Inside this catalog, you will find the collection that has it all—the most complete portfolio of cohesive gel breast implants, saline-filled implants, and tissue expanders.3-5 Our science, research, and development—the substantiating factors in the safety of every one of our products—give us the confidence to know that we are providing you and your patients with a high level of satisfaction.7,8 ‡Over 700 breast implant options. Committed to supporting surgeons and patients. Natrelle® is dedicated to offering you a full range of services for your office and your patients. Programs such as the Natrelle® Gel Rewards Program, Brilliant Distinctions® Consumer Loyalty Program, Natrelle® ConfidencePlus®, and ALLERGAN PARTNER PRIVILEGES® are designed to support your practice and patients every step of the way. And they’re only offered from Natrelle® and Allergan. Natrelle® is the #1 plastic surgery portfolio1,2,*,† *Based on surgeon survey data, December 2016 (N = 100). †Based on US market share data through November 2016 (N = 67). ART. SCIENCE. 8 9 ART. SCIENCE. Natrelle® 410 The Natrelle® Cohesive Collection Natrelle INSPIRA® Cohesive Natrelle INSPIRA® Soft Touch Natrelle INSPIRA® Expansion meets breast shaping Create a precise pocket for the breast shape you both envision. Only Natrelle® 133Plus Tissue Expanders include the FOURTÉ™ Expander Fill System. • FOURTÉ™ fills tissue expanders 4X faster than a 21-gauge needle9,*,† Natrelle® 133 Tissue Expanders • 30 years of clinical experience10 *Clinical significance has not been established. † Methodology The FOURTÉ™ Expander Fill System and 21-gauge needle are attached to 60-cc syringes filled with water. The injector starts the injection at maximum effort while the time is tracked. When the plunger reaches the end of the syringe barrel, the time is stopped and recorded. This is repeated 20 times, recorded, and compared. 10 11 Nikki Natrelle INSPIRA® Style SRF-415 Individual results may vary. Natrelle INSPIRA® Collection 12 13 Natrelle INSPIRA® Soft Touch Natrelle INSPIRA® Natrelle INSPIRA Cohesive ® Three unique silicone gels feature cross-linking technology for 3 distinct cohesivities. Highly Cohesive cohesive Cohesivity Level Cohesivity Level Cohesivity Level 1 2 3 Cohesivity Level Cohesivity Level Cohesivity Level 1 2 3 Cohesivity Level Cohesivity Level 1 2 3 55% more cohesive than level 111,† Natrelle INSPIRA® SMOOTH ROUND GEL IMPLANTS STYLES SCX, SSX, & SRX EXTRA-FULL PROFILE Low Low Plus Moderate Full eXtra-Full Smooth Cohesive (SCX) Smooth Soft Touch All Natrelle INSPIRA® Round Gel Breast Implants offer: • Systematic diameter sizing for simplified implant selection • Smooth or BIOCELL® textured surface • 5 projection style options • Matching sizers available Natrelle® offers the widest range of cohesivities for every breast, patient type, and aesthetic vision—whether it’s Three cohesivities. for reconstruction, revision, or augmentation.11 Countless possibilities.6,* *Over 700 breast implant options. † Methodology Breast implant gel was measured for material properties using the BTC-2000 ™. The BTC-2000 ™ applies a controlled vacuum, or negative pressure, to the gel while measuring the dynamic response of material deformation using a synchronized target laser. The gel for each device (n = 8 per group) was tested at 3 sites, all at or near the apex of the implant (anterior side). From those measurements, the gel cohesivity was calculated and the relative change was determined. Natrelle INSPIRA® Collection 14 15 16 Natrelle INSPIRA® SMOOTH ROUND GEL IMPLANTS STYLES SCM, SSM, & SRM MODERATE PROFILE Low Low Plus Moderate Full eXtra-Full Smooth Cohesive (SCM) Smooth Soft Touch (SSM) Smooth INSPIRA (SRM) Volume (cc) Diameter (cm) Projection (cm) SMOOTH ROUND GEL IMPLANTS STYLES SCL, SSL, & SRL LOW PROFILE Low Low Plus Moderate Full eXtra-Full Smooth Cohesive (SCL) Smooth Soft Touch (SSL) Smooth INSPIRA (SRL) Volume (cc) Diameter (cm) Projection (cm) TEXTURED ROUND GEL IMPLANTS 17 18 19 20 Natrelle ® 410 Style FM Individual results may vary. Natrelle ® 410 Anatomical Gel 21 22 23 Natrelle ® 410 ANATOMICAL GEL IMPLANTS STYLE FX FULL HEIGHT/EXTRA-FULL PROJECTION Catalog Number Volume (cc) Width (cm) Height (cm) (cm)breast augmentation dubai breast enlargement dubai breast implants dubai breast surgery dubai non surgical breast augmentation dubai breast surgery in uae boob job dubaiRe-sterilizable Sizer MX-410165 MSZLX625Cohesivity LevelCohesivity LevelCohesivity Level123 Designed to mirror the curve of a woman’s breast. Natrelle® 410 Anatomical Gel Breast Implants are filled with highly cohesive silicone gel and are designed to maintain their shape over time. Natrelle ® 410 Anatomical Gel Breast Implants have the most high-projection (≥ 6.0 cm) sizes available.3-5 Natrelle® 410 Anatomical Gel Breast Implants offer: • Shaped fullness • Highly cohesive gel • BIOCELL® textured surface • 4 projection style options • Matching sizers available Natrelle ® 410 Anatomical Gel Breast Implants MMLMModerate ProjectionMXFXLXMFFFFMLFFLMLLLFull HeightModerate HeightLow HeightLow ProjectionFull ProjectioneXtra-Full Projection 116 size options3 Offering the highest-projection implant—7.1 cm—in all 3 heights.3-5 Natrelle ® 410 Anatomical Gel 25 26 24 STYLE LF LOW HEIGHT/FULL PROJECTION Catalog Number Volume (cc) Width (cm) Height (cm) Projection (cm) Re-sterilizable Sizer LF-410125 125 9.5 7.6 3.7 MSZLF125 LF-410150 150 10.2 4.4 10.0 15.0 350-370 468-230 10.2 11.9 Paired for precision Natrelle® 133Plus delivers a seamless match between tissue expander and round breast implant. • 100% match (in base width and projection) to Natrelle INSPIRA®12,† • 83% match (in base width and projection) to Natrelle ® 41012,† Only Natrelle ® 133Plus Tissue Expanders include the FOURTÉ™ Expander Fill System • Patented 4-needle design fills tissue expanders 4X faster than a standard 21-gauge needle9,‡,§ • May save up to 9 minutes of expander fill time9,‡,§ Building on the success of the original Natrelle® 133— the #1 surgeon-selected tissue expander.2,* Blue tabs designed for suture accuracy. FOURTÉ™ Expander Fill System Blue orientation line assists in precise placement within the breast pocket. *Based on US market share data through November 2016 (N = 67). Natrelle ® 133Plus Tissue Expanders 36 37 WARNING: The strong rare-earth, permanent magnet contained in the Natrelle ® Style 133Plus Series Tissue Expanders is contraindicated where the magnetic field may affect other polarized devices (eg, pacemakers, drug infusion devices, artificial sensing devices, similar-type products, and MRI procedures). NOTE: All Natrelle ® 133Plus Tissue Expanders include the FOURTÉ™ Expander Fill System. STYLE 133P-FX FULL HEIGHT/ EXTRA PROJECTION Catalog Number Volume (cc) Width 39 Jessica Natrelle ® 133 Style MV, 400 cc Natrelle ® 410 Style FF, 425 cc Individual results may vary. Natrelle ® 133 Tissue Expanders 40 41 Natrelle ® 133 Tissue Expanders Natrelle ® 133 Tissue Expanders offer a precise match with Natrelle ® breast implants. All Natrelle ® 133 Tissue Expanders offer: • 84 options with or without suture tabs3 • BIOCELL® textured surface • 7 style options *Based on US market share data through November 2016 (N = 67). #1 surgeon-selected tissue expander with 30 years of clinical experience.2,10,* Natrelle ® 133 Tissue Expanders 43 WARNING: The strong rare-earth, permanent magnet contained in the Natrelle ® Style 133 Series Tissue Expanders is contraindicated where the magnetic field may affect other polarized devices (eg, pacemakers, drug infusion devices, artificial sensing devices, similar-type products, and MRI procedures). breast augmentation dubai breast enlargement dubai breast implants dubai breast surgery dubai non surgical breast augmentation dubai breast surgery in uae boob job dubai 44 45 FOURTÉ™ Expander Fill System Description Catalog Number Four-pronged 21-gauge, 1¾” butterfly needles, tubing, luer adapter F-4444 Natrelle ® tissue expander accessories Natrelle® breast implant accessories Sizer Templates Description Catalog Number Plastic measuring templates for Styles 133Plus and 133 Tissue Expanders, nonsterile: Styles 133P-FX and 133FX Sizer Template Set 30-00038 Styles 133P-FV and 133FV Sizer Template Set 30-00018 Styles 133P-MX and 133MX Sizer Template Set 30-00039 Styles 133P-MV and 133MV Sizer Template Set 30-00017 Styles 133P-SX and 133SX Sizer Template Set 30-00040 Styles 133P-SV and 133SV Sizer Template Set breast augmentation dubai breast enlargement dubai breast implants dubai breast surgery dubai non surgical breast augmentation dubai breast surgery in uae boob job dubai 30-00035 Styles 133P-LV and 133LV Sizer Template Set 30-00016 MAGNA-FINDER® Xact Port Finders Description Catalog Number Xact2 External locating device with dermal indicator for use with Style 133Plus Tissue Expanders for locating MAGNA-SITE® injection sites (provided nonsterile) 30-00034 Xact External locating device for use with Style 133 Tissue Expanders for locating MAGNA-SITE® injection sites (provided nonsterile) 30-00032 21-G Needle Infusion Set Description Catalog Number 21-gauge, 1¾” butterfly needle, tubing, luer adapter 30-00012 Universal Fill Kit Description Catalog Number 60-cc syringe, 122-cm transfer set with piercing device, 25-cm extension tube, 2-way check valve 30-00033 Diaphragm Valve Fill Tube and Reflux Valve Description Catalog Number Diaphragm valve fill tube and reflux valve 25-00017 BIOCELL® Delivery Assistance Sleeve Description Catalog Number Clear, sterile sleeve 27-000001 The above accessories are not eligible for return for credit. The above accessories are not eligible for return for credit. Accessories 47 46 Warranty program brochure ConfidencePlus® warranty program Get more coverage and confidence with Natrelle ® Gel implants than with any other breast implant warranty— ONLY with Natrelle ® ConfidencePlus ®. • The ONLY warranty with a 10-year FREE breast implant replacement in the event of capsular contracture (Baker Grade III/IV) • The ONLY warranty to cover primary AND revision surgeries in the event of capsular contracture (Baker Grade III/IV) • The ONLY warranty that allows you to choose ANY style and size of Natrelle® Gel breast implant for replacement in the event of capsular contracture (Baker Grade III/IV) or rupture • Lifetime product replacement for all gel implants in the event of rupture • Financial assistance up to $3500 for 10 years in the event of implant rupture For more information about the ConfidencePlus ® warranty program, please visit Natrelle.com/warranty. Accessories Warranty Program 48 49 Additional information CAUTION: United States Federal Law restricts these devices to sale by, or on the order of, a licensed physician. PRODUCT SUPPLIED STERILE: Please see Directions for Use at www.allergan.com/labeling/usa.htm for additional product information including warnings, precautions, adverse reactions, and instructions for use. Natrelle ® Styles 133Plus and 133 Tissue Expander Sizing Templates and MAGNA-FINDER® breast augmentation dubai breast enlargement dubai breast implants dubai breast surgery dubai non surgical breast augmentation dubai breast surgery in uae boob job dubai Xact2 and Xact are supplied nonsterile. DIMENSIONS: Dimensions listed are typical and are measured with the implant placed on a flat surface. Not every implant will conform to the dimensions given. Slight variations may occur. RECOMMENDED FILL VOLUMES: Following recommended fill volumes for saline-filled breast implants can decrease t breast augmentation dubai breast enlargement dubai breast implants dubai breast surgery dubai non surgical breast augmentation dubai breast surgery in uae boob job dubai he possibility of shell wrinkling and crease-fold failure.13 Committed to advancing the field of breast aesthetics. We have advanced the medical aesthetics industry through scientific discovery, market innovation, and partnering with the medical communities that we serve. Building on 50 years of scientific research and development, we are taking our passion for innovation and applying it to the consumer realm. That’s why we’ve created the Natrelle ® Portfolio—specially designed to give you and your patients more options to help you achieve the desired results. Additional Information Warranty Program 50 51 ART. SCIENCE. Shaping the future with you Natrelle® is the #1 plastic surgery portfolio.1,2,*,† Natrelle INSPIRA® Collection #1 selected round gel implant collection in the US.1,* Natrelle ® 410 #1 selected anatomically shaped implant in the US.2,† Natrelle® 133 Series #1 selected tissue expander in the US.2,† Natrelle INSPIRA® Cohesive Most cohesive round gel breast implant in the US.11 *Based on surgeon survey data, December 2016 (N = 100). †Based on US market share data through November 2016 (N = 67). To order breast aesthetics products, please call Customer Care at 1-800-766-0171. © 2017 Allergan. All rights reserved. All trademarks are the property of their respective owners. Natrelle.com NAT64504_v2 03/17 170324 References: 1. Data on file, Allergan, December 2016; Plastic Surgery Monthly Tracker: Breast Implants & Tissue Expanders. 2. Data on file, Allergan, November 2016; Breast Implant + Tissue Expander Share Tracker. 3. More of Everything: Natrelle® Product Catalog. Irvine, CA: Allergan; 2015. 4. Our products: breast implants. Mentor Worldwide LLC website. http://www.mentorwwllc.com/global-us/Breast.aspx. Updated April 2016. Accessed February 14, 2017. 5. Sientra® HSC & HSC + Breast Implant Product Catalog. Santa Barbara, CA: Sientra, Inc., 2015. http://sientra.com/Content/pdfs /MDC-0177%20R2%20HSCHSC%2B%20Breast%20Implants%20Product%20Catalog.pdf. Accessed February 14, 2017. 6. Data on file, Allergan, January 2017; Allergan Plastic Surgery Order Form. 7. Natrelle® Silicone-Filled Breast Implants and Natrelle INSPIRA® Breast Implants: Smooth & BIOCELL® Texture Directions for Use, 2016. 8. Natrelle® 410 Highly Cohesive Anatomically Shaped Silicone-Filled Breast Implants Directions for Use, 2014. 9. Data on file, Allergan, January 4, 2016; Protocol MM-1225-FR. 10. Data on file, Allergan, July 14, 1986; FDA Section 510(k) marketing approval letter. 11. Data on file, Allergan, February 8, 2017; Study Report MD16075-DV2. 12. Data on file, Allergan, January 6, 2017; Study Report MD16076-DV. 13. Natrelle ® Saline-Filled Breast Implants: Smooth & BIOCELL® Texture Directions for Use, 2014. Additional Information Founded in 1979, Nagor™ is the only British company dedicated to the specialist design, manufacture and supply of high quality breast implants and related medical devices. Nagor’s commitment to quality is demonstrated by ongoing research and development with investment in manufacturing processes, supported by the most demanding quality control management. Nagor’s products are manufactured under a quality management system in accordance with EN ISO 13485 and products intended for sale in Europe are CE certified according to the applicable European medical device regulations. All dimensions and weights are approximate and slight variations may occur between the product catalogue and the product label. 4 5 Introduction to Breast Aesthetics Shapes • Round: Impleo™ • Anatomical: CoGel™ SiloGard™ 360° Barrier Layer All Nagor™ implants are manufactured with high performance silicone elastomer layers to enhance shell integrity and have a unique SiloGard™ 360° barrier layer to minimise gel diffusion. Shell surface • Smooth • Nagotex® mid-textured SiloGel Twist™ 6th generation soft form stable high cohesive silicone gel. GCA comfort guarantee Lifetime product replacement warranty, for details view our brochure. Instructions for use We encourage surgeons to refer to the package insert supplied with every Nagor® product for instructions for use, indications and contraindications. Round Silicone Gel-Filled implants Anatomical Silicone Gel-Filled implants Profile Moderate High Extra High Textured Surface Soft Form Stable High Cohesive Gel 100% Fill IMP-MR IMP-HR IMP-EHR Smooth Surface Soft Form Stable High Cohesive Gel 100% Fill IMP-SMR IMP-SHR IMP-SEHR CoGel® System Low Moderate High Full Height XF1 XF2 XF3 Moderate Height XM1 XM2 XM3 Low Height XL1 XL2 XL3 Breast Aesthetics 6 Nagotex® Mid-textured Surface. Tapered edges for less visibility and palpability. Firm upper pole for shape maintenance. Higher projection for added lift. SiloGard™ 360° Barrier. SiloGel™ form stable high cohesive gel. 7 Orientation marker dots. Gel-filled and Inflatable Sizers available for core sizes. XF1 (F) Full Height (1) Low Projection XM1 (M) Moderate Height (1) Low Projection XL1 (L) Low Height (1) Low Projection XL2 (L) Low Height (2) Moderate Projection XL3 (L) Low Height (3) High Projection XM2 (M) Moderate Height (2) Moderate Projection XM3 (M) Moderate Height (3) High Projection XF2breast augmentation dubai breast enlargement dubai breast implants dubai breast surgery dubai non surgical breast augmentation dubai breast surgery in uae boob job dubai(F) Full Height (2) Moderate Projection XF3 (F) Full Height (3) High Projection Greater Precision for Individualised Augmentation. 7 WIDTH / HEIGHT W H LVC P A PROJECTION / ARC IMPLANT CATALOGUE MENTOR® BREAST IMPLANTS © Mentor Worldwide LLC 2018 062724-161103 F RO N T PA G E F I N I S H E S S H O R T In 2002, we completed a plant in Leiden, The Netherlands. At 6,000 square meters, it is one of the largest of its kind in the world. This plant contains an automated breast implant dipping machine, which produces every implant shell in a consistently uniform manner. To meet an ever-increasing demand for our products, plant produces more than 300,000 breast implants a year, distributed to more than 100 nations. At Mentor all our products are made under strict standards of design and testing. F RO N T PA G E F I N I S H E S S H O R T F RO N T PA G E F I N I S H E S S H O R T Founded in 1969, Mentor Worldwide LLC is a leading manufacturer and supplier of medical products for the global Aesthetic medicine market and Reconstructive surgery. As the world’s leading maker of high-quality breast implants for over 30 years, our experience results in quality products that you can rely on. Headquartered in Irvine, California, Mentor has manufacturing and research operations in the United States and the Netherlands. In 1995, Mentor became the first breast implant manufacturer to achieve CE-marking for its products. Mentor has worked closely with surgeons throughout the world to develop innovative products such as MENTOR® CONTOUR PROFILE™ BECKER™ 35 Expander/ Breast Implant and the MENTOR® CPG™ breast augmentation dubai breast enlargement dubai breast implants dubai breast surgery dubai non surgical breast augmentation dubai breast surgery in uae boob job dubai Gel Breast Implants. Mentor’s manufacturing capability is exceptional. We have substantial experience in biomaterials and biopolymers manufacturing. At the same time, our regulatory expertise has enabled the Company to bring products to market in the world’s most stringently regulated health care environments. Mentor is a manufacturer with a strong customer focus. Our sales representatives are skilled in technical product issues, enabling them to act as a valuable information F RO N T PA G E F I N I S H E S S H O R T resource. For questions or additional information, please contact your local Mentor branch, Johnson & Johnson office or distributor. On Jan 23, 2009, Mentor was acquired by Johnson & Johnson, one of the leading providers of suture, mesh, hemostats and other products for a wide range of surgical procedures. By joining forces, we aspire to be the trusted global leader in aesthetic medicine among both consumers and professionals by providing a broad range of innovative, science and clinical-based solutions to maintain, enhance, and restore self-esteem and quality of life. Simply said, our goal is to make life more beautiful. F RO N T PA G E F I N I S H E S S H O R T A More Evolved Implant MemoryGel™ BREAST IMPLANTS About MemoryGel™ Implants MENTOR® MemoryGel™ Breast Implants feature a proprietary cohesive silicone gel formulation used to fill all MENTOR® Silicone Gel-Filled Breast Implants around the world. By varying the components of the gel, Mentor is able to produce a wide selection of products ranging from very soft to very firm. • Strict US and EU manufacturing standards • Highly compliant shell for ease of placement • Lifetime product replacement policy • MENTORPromise Protection Plan, the most comprehensive protection plan available1 • Moderate Plus, Xtra Moderate Plus, High, Xtra High and Ultra High projection • Proprietary silicone gel formula for a natural touch that resembles breast tissue F RO N T PA G E F I N I S H E S S H O R T MemoryGel™ Breast Implants MemoryGel™ Breast Implants Product Scale Product Profile Cohesive I™ Cohesive II™ Cohesive III™ Round Moderate Plus Memory GelTM Xtra Moderate Plus Round High Memory GelTM Xtra High Round Ultra High CPGTM Gel Breast Implant Round BECKERTM 25 Expander/ Breast Implant CONTOUR PROFILETM BECKER™ Expander/ Breast Implant 35 F RO N T PA G E F I N I S H E S S H O R T All MENTOR® Silicone Gel-Filled Breast Implants contain gel that is cohesive, safe and aesthetically pleasing’. Cohesive I™ The standard cohesive level gel used in Mentor® Breast Implants. This is the softest gel and has been preferred by millions of women worldwide. Products are available textured and smooth Moderate Plus, Xtra Moderate Plus, High, Xtra High and Ultra High projection Gel Breast Implants as well as the MENTOR® Becker™ Expander/Breast Implants. Cohesive II™ A slightly firmer gel, for surgeons wanting a firmer feeling implant. This gel is used in textured Moderate Plus, High Profile Gel Breast Implants and MENTOR® Contour Profile™ Becker™ Expander/Breast Implants. Cohesive III™ Mentor’s most cohesive gel, providing shape retention with a pleasing level of firmness for optimal aesthetic results. This gel is used in the Mentor® CPG™ Gel Breast Implants. All Cohesive, all the time.™ Advanced MemoryGel™ Breast Implants. The more evolved implant. F RO N T PA G E F I N I S H E S S H O R T PROVEN TEXTURE YOU CAN TRUST MENTOR® CPG™ Implants are proven to have a low risk of capsular contracture and rotation in primary augmentation patients at 10 years and are covered by the most comprehensive warranty in the market.2 Not a head to head study. Based on the comparison of key complication rates reported in the 10 year Core Studies for MemoryShape®/ CPG™ Gel Breast Implants, NATRELLE™ 410 TruForm™ 3 Gel Breast Implants. *Specification for MemoryGel™ Round Gel implants The third-party trademarks used herein are trademarks of their respective owners. MENTOR®: SILTEX™ Texture3* Allergan®: Biocell Texturing3 Surface Description Manufacturing Technique Pore Size Width (μm) Pore Size Depth/ Height (μm) Edge(μm) Distribution Depression or Nodules Gentle patterned surface Aggressive, open-pored surface with cuboid-shape depressions and a stilted edge Negative contact imprint off polyurethane texturing foam Shell is pressed onto bed of finely granular salt: lost salt technique 70-150 600-800 40-100 (height) 100-150 (depth) 0 100-150 Regular Irregular Nodules Depressions F RO N T PA G E F I N I S H E S S H O R T PROVEN PERFORMANCE Reliable implants continuously delivering world class clinical results. The lowest reported risk of key complications in primary breast augmentation for MENTOR® CPG™ Gel Breast Implants at 10 years2 Primary Augmentation MENTOR®CPG Breast Implant Core Study, Long Term 10 years4 Allergan® Natrelle® Breast Implant Core Study, Long Term 10 years5,6 Capsular Contracture (Baker III/IV) Suspected or Confirmed Rupture (MRI Cohort) Device Removal (with or without replacement) Rotation 3.6% 6.6% 9.2% 1.3% 9.2% 17.7% 19.6% 4.7% Kaplan-Meier estimated risk of first occurrence. Data presented in table is not based on a head to head comparison of the Mentor® CPG™ Gel Breast Implant and the Allergan® Natrelle® 410 Breast Implant Core Studies. F RO N T PA G E F I N I S H E S S H O R T 8080 PERSON YEARS OF FOLLOW UP DATA 43 SITES 955 SUBJECTS Multi-center Core Study F RO N T PA G E F I N I S H E S S H O R T PROVEN PEACE of MIND To our Mentor customers and patients, we pledge our commitment to excellence. That is why we back our MemoryGelTM Breast Implants with the most comprehensive plan in the industry. Mentor Warranties & Product Replacement Policy † In the event of a confirmed rupture or deflation (leaking) of any MENTOR® Breast Implant due to wear or delamination requiring surgical intervention, regardless of the age of the implant, Mentor will provide a free replacement of a MENTOR® Breast Implant of any size in the same or similar style as the originally implanted product. α When a replacement surgery of a MENTOR® Gel-Filled Breast Implant is required due to confirmed rupture occurs within ten (10) years from the date of implantation, provided that eligibility is proven and confirmed by Mentor based on its assessment and evaluation, Mentor will pay uninsured, out-of-pocket costs for operating room, anesthesia and/or surgical expenses directly related to revision surgery up to a maximum aggregate amount of €1000. Operating room and anesthesia charges shall be given payment priority. In such cases, the request for financial assistance under the MentorPromise Protection Plan must be made to your surgeon. Financial assistance does not imply a loan to you. β In the events of capsular contracture (Baker III/IV), double capsule or late-stage seroma in augmentation surgery of a MENTOR® Gel-Filled Breast Implant, Mentor will provide a replacement of a MENTOR® Gel-Filled Breast Implant, free of charge for the period of ten (10) years from the date of implantation, provided that eligibility is proven and confirmed by Mentor based on its evaluation of explanted product and assessment of all required documentation. Mentor will provide a replacement MENTOR® Product of any size in the same or similar style as the originally implanted product. For further information about MENTOR® CPG™ Breast Implants or any other MENTOR® Products, talk to your Mentor sales representative today or visit mentorwwllc.eu $ 10 YEAR FREE AND AUTOMATIC ENROLLMENT MENTORPromise Protection Plan Overview FREE CONTRALATERAL IMPLANT at your surgeon’s request FREE PRODUCT REPLACEMENT IN THE EVENTS OF CAPSULAR CONTRACTURE (Baker III/IV), DOUBLE CAPSULE AND LATE STAGE SEROMAβ UP TO €1000 FINANCIAL ASSISTANCE COVERAGE FOR RUPTUREα FREE LIFETIME PRODUCT REPLACEMENT FOR RUPTURE† F RO N T PA G E F I N I S H E S S H O R T Uncover the unique SILTEXTM Texture of MENTOR® CPGTM Gel Breast Implants today. Talk to your Mentor Sales Representative or visit mentorwwllc.eu for more information. A closer look at MENTOR® patented SILTEX™ Texture SEM images of SILTEXTM Texture Anterior View Radius View Posterior View Cross Section View SILTEX™ Texture providing you and your patients with peace of mind. F RO N T PA G E F I N I S H E S S H O R T RIGHT FROM THE START. MADE TO MATCH Expansion matters. Texture you can trust. Natural shape Presenting the: CPX™4 Breast Tissue Expander and CPG ™ Gel Breast Implants, giving you greater control over the desired shape in two stage breast reconstruction: 1. MENTOR® is the only company to offer a breast tissue expander with proven directional lower pole expansion7 2. CPG Implants can help achieve a smooth transition from tissue to implant8 3. Unsurpassed Peace of Mind F RO N T PA G E F I N I S H E S S H O R T γ The third-party trademarks used hereibreast augmentation dubai breast enlargement dubai breast implants dubai breast surgery dubai non surgical breast augmentation dubai breast surgery in uae boob job dubai are trademarks of their respective owners CPX™4 Breast Tissue Expander Post operatively adjustable device PATIENT COMFORT Incorporates two principle innovations that were designed to enhance patient comfort while maintaining the same expansion profile9 TEXTURED SURFACE The patented SILTEXTM Texture has a surface substantially free of pores and interstices The manufacturing process for the SILTEXTM Texture on MENTOR® Breast Tissue Expanders does not require the use of salt or sugar crystals. EASY TO DETECT The CENTERSCOPE® Magnetic Detection Device locates the magnetic injection dome for absolute ease and acuracy. The injection dome contains a rare earth magnet that is 48% stronger than previous expanders9 NATURAL SHAPE The Combination of the Buffer- ZoneTM Self-Sealing Patch and the posterior Dacron® Patch provides directionally focused expansion to maximize lower pole expansion to mimic the shape of a natural breast γ F RO N T PA G E F I N I S H E S S H O R T F RO N T PA G E F I N I S H E S S H O R T MENTOR® MemoryGel™ Xtra Breast Implants She’s confident in what she wants - An innovation in breast implants from the brand you trust. Soft, Natural Feelδ10 Xtra Fullness11 Xtra Firmness11 Xtra Projection11 δ In-person consumer survey with 452 respondents. F RO N T PA G E F I N I S H E S S H O R T F RO N T PA G E F I N I S H E S S H O R T Round Expanders Other CPG Siltex™ Round Breast Implants, Cohesive ITM Smooth Round Breast Implants, Cohesive ITM Siltex™ and Smooth MemoryGel™ Xtra Breast Implants Siltex™ Round Breast Implants, Cohesive IITM CONTOUR PROFILE™ Tissue Expanders BECKER™ Expander/Breast Implants Other Expanders Accessories Saline products Sizers CPG™ Gel Breast Implants, Cohesive III™ F RO N T PA G E F I N I S H E S S H O R T Round SILTEX™ Round Breast Implants, Moderate Plus Profile, Cohesive ITM Vol cc Diameter cm Proj cm Catalog # Resterilizable Gel Sizerε Round Gel Breast Implants, Cohesive I™ - 2 - ε Resterilizable up to 10 times. Round Round Gel Breast Implants, Cohesive I™ SILTEX™ Round Breast Implants, High Profile, Cohesive I™ Vol cc Diameter cm Proj cm Catalog # Resterilizable Gel Sizerε ε Resterilizable up to 10 times. Round Round Gel Breast Implants, Cohesive I™ SILTEX™ Round Breast Implants, Ultra High Profile, Cohesive I™ Vol cc Diameter cm Proj cm Catalog # Resterilizable Gel Sizerε - 4 - ε Resterilizable up to 10 times. Round Round Gel Breast Implants, Cohesive I™ - 5 - Round Round Gel Breast Implants, Cohesive I™ Smooth Round Breast Implants, Moderate Plus Profile, Cohesive I™ Vol cc Diameter cm Proj cm Catalog # Resterilizable Gel Sizerε ε Resterilizable up to 10 times. Round Round Gel Breast Implants, Cohesive I™ Smooth Round Breast Implants, High Profile, Cohesive I™ Vol cc Diameter cm Proj cm Catalog # Resterilizable Gel Sizerε ε Resterilizable up to 10 times. Round Round Gel Breast Implants, Cohesive I™ Smooth Round Breast Implants, Ultra High Profile, Cohesive I™ Vol cc Diameter cm Proj cm Catalog # Resterilizable Gel Sizerε ε Resterilizable up to 10 times. Round - 9 - Round Gel Breast Implants, Cohesive I™ Round SILTEX™ Round Moderate Plus Profile Xtra Gel Breast Implants Vol cc Diameter cm Proj cm Catalog # Resterilizable Gel Sizerε - 10 - MemoryGelTM Xtra Breast Implants ε Resterilizable up to 10 times. Round - 11 - MemoryGelTM Xtra Breast Implants SILTEX™ Round High Profile Xtra Gel Breast Implant Vol cc Diameter cm Proj cm Catalog # breast augmentation dubai breast enlargement dubai breast implants dubai breast surgery dubai non surgical breast augmentation dubai breast surgery in uae boob job dubai Resterilizable Gel Sizerε 150 8,4 4,2 THPX-150 RSZTHPX150 175 9,0 4,4 THPX-175 RSZTHPX175 200 9,4 4,5 THPX-200 RSZTHPX200 230 9,8 4,8 THPX-230 RSZTHPX230 255 10,1 4,9 THPX-255 RSZTHPX255 285 10,5 5,1 THPX-285 RSZTHPX285 325 10,8 5,4 THPX-325 RSZTHPX325 340 11,1 5,4 THPX-340 RSZTHPX340 365 11,4 5,5 THPX-365 RSZTHPX365 405 11,6 5,9 THPX-405 RSZTHPX405 425 11,9 5,8 THPX-425 RSZTHPX425 455 12,1 6,0 THPX-455 RSZTHPX455 470 12,3 5,9 THPX-470 RSZTHPX470 515 12,6 6,2 THPX-515 RSZTHPX515 570 13,2 6,3 THPX-570 RSZTHPX570 620 13,4 6,5 THPX-620 RSZTHPX620 680 14,0 6,6 THPX-680 RSZTHPX680 725 14,5 6,7 THPX-725 RSZTHPX725 765 14,7 6,7 THPX-765 RSZTHPX765 ε Resterilizable up to 10 times. Round - 12 - MemoryGelTM Xtra Breast Implants Smooth Round Moderate Plus Profile Xtra Gel Breast Implant Vol cc Diameter cm Proj cm Catalog # Resterilizable Gel Sizerε ε Resterilizable up to 10 times. Round MemoryGelTM Xtra Breast Implants Smooth Round High Profile Xtra Gel Breast Implant Vol cc Diameter cm Proj cm Catalog # Resterilizable Gel Sizerε ε Resterilizable up to 10 times. Round Round Gel Breast Implants, Cohesive II™ SILTEX™ Round Breast Implants, Moderate Plus Profile, Cohesive II™ Vol cc Diameter cm Proj cm Catalog # Resterilizable Gel Sizerε ε Resterilizable up to 10 times. Round Round Gel Breast Implants, Cohesive II™ SILTEX™ Round Breast Implants, High Profile, Cohesive II™ Vol cc Diameter cm Proj cm Catalog # Resterilizable Gel Sizerε ε Resterilizable up to 10 times. Round - 16 - CPG MENTOR® CPG™ Gel Breast Implants, Cohesive III™ Diagrams not to scale, for reference only. LOWER POLE ARC (LPA) = Length measured along the lower pole of the implant running from the bottom of the implant (Point B) upto the midway point (Point A) including a 0,5 cm of tissue thickness. MIDWAY POINT HEIGHT LOWER POLE ARC MEASUREMENT ASSUMES 0,5 CM OF TISSUE THICKNESS 50% 50% 0,5 cm MENTOR® CPG™ BREAST IMPLANT NAMING LEGEND Cohesive Level Implant Height Implant Projection III 3 Tall 3 Medium 2 Low 1 High 3 Moderate Plus 2 Moderate 1 KEY: DIGIT 1 = COHESIVE LEVEL DIGIT 2 = HEIGHT OF IMPLANT DIGIT 3 = PROJECTION OF IMPLANT UNDERSTANDING THE LOWER POLE ARC - 17 - CPG CPG™ Gel Breast Implants, Cohesive III™ Vol cc Width cm Height cm Projection cm Lower Pole Arc A-B cm Catalog # Resterilizable Gel Sizerε CPG™ Implants 331, Cohesive III™, Tall Height, Moderate Projection Vol cc Width cm Height cm Projection cm Lower Pole Arc A-B cm Catalog # Resterilizable Gel Sizerε CPG™ Implants 321, Cohesive III™, Medium Height, Moderate Projection ε Resterilizable up to 10 times. - 18 - CPG CPG™ Gel Breast Implants, Cohesive III™ Vol cc Width cm Height cm Projection cm Lower Pole Arc A-B cm Catalog # Resterilizable Gel Sizerε CPG™ Implants 311, Cohesive III™, Low Height, Moderate Projection - 19 - ε Resterilizable up to 10 times. CPG CPG™ Gel Breast Implants, Cohesive III™ CPG™ Implants 322, Cohesive III™, Medium Height, Moderate Plus Projection Vol cc Width cm Height cm Projection cm Lower Pole Arc A-B cm Catalog # Resterilizable Gel Sizerε - 20 - Vol cc Width cm Height cm Projection cm Lower Pole Arc A-B cm Catalog # Resterilizable Gel Sizerε CPG™ Implants 332, Cohesive III™, Tall Height, Moderate Plus Projection ε Resterilizable up to 10 times. CPG Vol cc Width cm Height cm Projection cm Lower Pole Arc A-B cm Catalog # Resterilizable Gel Sizerε CPG™ Implants 312, Cohesive III™, Low Height, Moderate Plus Projection CPG™ Gel Breast Implants, Cohesive III™ - 21 - ε Resterilizable up to 10 times. CPG CPG™ Gel Breast Implants, Cohesive III™ - 22 - Vol cc Width cm Height cm Projection cm Lower Pole Arc A-B cm Catalog # Resterilizable Gel Sizerε CPG™ Implants 323, Cohesive III™, Medium Height, High Projection Vol cc Width cm Height cm Projection cm Lower breast augmentation dubai breast enlargement dubai breast implants dubai breast surgery dubai non surgical breast augmentation dubai breast surgery in uae boob job dubai CPG Vol cc Width cm Height cm Projection cm Lower Pole Arc A-B cm Catalog # Resterilizable Gel Sizerε CPG™ Implants 313, Cohesive III™, Low Height, High Projection CPG™ Gel Breast Implants, Cohesive III™ - 23 - ε Resterilizable up to 10 times. CPG MENTOR® CONTOUR PROFILE™ Breast Tissue Expanders / CPG™ Gel Breast Implants Sizing Guide / Two-Stage Breast Reconstruction STAGE 1 Selection of the CPX4™Expander Styles 9100 – Low Height Volume cc Width cm Height cm Proj. cm Catalog # CPG™ Implant 311 Cohesive III™, Low Height, Moderate Projection Volume cc Width cm Height cm Proj. cm Catalog # 180 11,0 9,8 3,7 334-1101 210 11,5 10,3 3,9 334-1151 270 12,5 11,2 4,2 334-1251 300 13,0 11,6 4,4 334-1301 375 14,0 12,5 4,7 334-1401 460 15,0 13,4 5,1 334-1501 510 15,5 13,8 5,2 334-1551 560 16,0 14,3 5,4 334-1601 615 16,5 14,7 5,6 334-1651 CPG™ Implant 311 Cohesive III™, Low Height, Moderate Projection Volume cc Width cm Height cm Proj. cm Catalog # Styles 9200 – Medium Height Volume cc breast augmentation dubai breast enlargement dubai breast implants dubai breast surgery dubai non surgical breast augmentation dubai breast surgery in uae boob job dubai cm Catalog # - 24 - CPG *PLEASE NOTE: The CONTOUR PROFILE™ Tissue Expander Injection Dome is not MRI compatible. For detailed indications, contraindications, warning and precautions associated with the use of this device, please refer to the Product Insert Data Sheet. Individual implant dimensions may vary slightly in products of this type. Not all units conform exactly to the dimensions noted. CPG™ Implant 312 Cohesive III™, Low Height, Moderate Plus Projection Volume cc Width cm Height cm Proj. cm Catalog # CPG™ Implant 313 Cohesive III™, Low Height, High Projection Volume cc Width cm Height cm Proj. cm Catalog # Selection of CPG™ Gel Breast Implant to use as a long-term implant after expansion is complete. STAGE 2 - 25 - CPG™ Implant 312 Cohesive III™, Low Height, Moderate Plus Projection Volume cc Width cm Height cm Proj. cm Catalog # CPG™ Implant 313 Cohesive III™, Low Height, High Projection Volume cc Width cm Height cm breast augmentation dubai breast enlargement dubai breast implants dubai breast surgery dubai non surgical breast augmentation dubai breast surgery in uae boob job dubai Height cm Proj. cm Catalog # Styles 9300 – Tall Height Volume cc Width cm Height cm Proj. cm Catalog # 250 10,1 10,7 5,6 354-9321 350 11,3 11,8 6,0 354-9322 450 12,3 12,9 6,5 354-9323 550 13,2 13,8 6,9 354-9324 650 14,0 14,6 7,3 354-9325 750 14,6 15,3 7,6 354-9326 850 15,4 15,9 7,9 354-9327 CPG™ Implant 321 Cohesive III™, Medium Height, Moderate Projection Volume cc Width cm Height cm Proj. cm Catalog # CPG™ Implant 331 Cohesive III™, Tall Height, Moderate Projection Volume cc Width cm Height cm Proj. cm Catalog # MENTOR® CONTOUR PROFILE™ Breast Tissue Expanders / CPG™ Gel Breast Implants Sizing Guide / Two-Stage Breast Reconstruction STAGE 1 Selection of the CPX4™Expander CPG CPG™ Implant 322 Cohesive III™, Medium Height, Moderate Plus Projection Volume cc Width cm Height cm Proj. cm Catalog # CPG™ Implant 323 Cohesive III™, Medium Height, High Projection Volume cc Width cm Height cm Proj. cm Catalog # CPG™ Implant 332 Cohesive III™, Tall Height, Moderate Plus Projection Volume cc Width cm Height cm Proj. cm Catalog # CPG™ Implant 333 Cohesive III™, Tall Height, High Projection Volume cc Width cm Height cm Proj. cm Catalog # - 27 - *PLEASE NOTE: The CONTOUR PROFILE™ Tissue Expander Injection Dome is not MRI compatible. For detailed indications, contraindications, warning and precautions associated with the use of this device, please refer to the Product Insert Data Sheet. Individual implant dimensions may vary slightly in products of this type. Not all units conform exactly to the dimensions noted. Selection of CPG™ Gel Breast Implant to use as a long-term implant after expansion is complete. STAGE 2 CPG - 28 - Expanders CPX Breast Tissue Expander BufferZone™ Self-sealing patch and posterior Dacron® Patch. • Protecting the chest wall whilst driving lower pole expansion to mimic the shape of the natural breast. Improved stronger magnet.ζ • Easier to locate injection dome for larger patients. Enhanced smooth, flat injection dome and shell pliability.ζ • Helps ease insertion and removal through incision. Better more pliant proprietary BufferZone™ Patch.ζ • Enhanced patient comfort. Patented SILTEX Texture. • Prevents the pooling or sequestration of body fluids. Implant matching. • Matching range of definitive implants to be used after tissue expansion. ζ Compared with the MENTOR® CPX2™ and CPX3™ Breast Tissue Expanders. BufferZone™ Self-sealing patch and posterior Dacron® Patch. • Protecting the chest wall whilst driving lower pole expansion to mimic the shape of the natural breast. Improved stronger magnet.* • Easier to locate injection dome for larger patients. Enhanced smooth, flat injection dome and shell pliability.* • Helps ease insertion and removal through incision. Better more pliant proprietary BufferZone™ Patch.* • Enhanced patient comfort. ® Texture. • Prevents the pooling or sequestration of body fluids. • Matching range of definitive implants to be used after tissue expansion. Patented SILTEX Implant matching. *Compared with the MENTOR® CPX2™ and CPX3™ Breast Tissue Expanders. Mentor CPX4 Breast Tissue Expander Expanders - 29 - 27 Expanders CONTOUR PROFILE™ Tissue Expanders CPX™4 Breast Tissue Expander, Low Height, Style 8100 η Volume cc Width cm Height cm Projection cm Catalog # 250 11,4 8,1 6,1 354-8121 350 12,7 9,4 6,5 354-8122 450 14,0 10,2 7,1 354-8123 550 15,0 10,9 7,4 354-8124 650 15,7 11,2 7,9 354-8125 750 16,5 11,9 8,1 354-8126 CPX™4 Breast Tissue Expander, Medium Height, Style 8200 η Volume cc Width cm Height cm Projection cm Catalog # CPX™4 Breast Tissue Expander, Tall Height, Style 8300η Volume cc Width cm Height cm Projection cm Catalog # η Includes CENTERSCOPETM Magnetic Detection Device PLEASE NOTE: Contour Profile™ Tissue Expanders are not MRI compatible Note: Individual implant dimensions may vary slightly in products of this type. Not all units will conform exactly to the dimensions noted above - 30 - Expanders η Includes CENTERSCOPETM Magnetic Detection Device PLEASE NOTE: Contour Profile™ Tissue Expanders are not MRI compatible Note: Individual implant dimensions may vary slightly in products of this type. Not all units will conform exactly to the dimensions noted above MENTOR® CPX™4 Breast Tissue Expander with Suture Tabs Low Height, Style 9100η Volume cc Width cm Height cm Projection cm Catalog # 250 11,4 8,1 6,1 354-9121 350 12,7 9,4 6,5 354-9122 450 14,0 10,2 7,1 354-9123 550 15,0 10,9 7,4 354-9124 650 15,7 11,2 7,9 354-9125 750 16,5 11,9 8,1 354-9126 MENTOR® CPX™4 Breast Tissue Expander with Suture Tabs Medium Height, Style 9200η Volume cc Width cm Height cm Projection cm Catalog # 275 10,7 9,3 6,2 354-9221 350 11,7 10,0 6,6 354-9222 450 12,7 10,8 7,0 354-9223 550 13,5 11,7 7,4 354-9224 650 14,6 12,6 7,6 354-9225 800 15,6 13,3 8,0 354-9226 MENTOR® CPX™4 Breast Tissue Expander with Suture Tabs Tall Height, Style 9300η Volume cc Width cm Height cm Projection cm Catalog # 250 10,1 10,7 5,6 354-9321 350 11,3 11,8 6,0 354-9322 450 12,3 12,9 6,5 354-9323 550 13,2 13,8 6,9 354-9324 650 14,0 14,6 7,3 354-9325 750 14,6 15,3 7,6 354-9326 850 15,4 15,9 7,9 354-9327 CONTOUR PROFILE™ Tissue Expanders - 31 - Expanders MENTOR® BECKER™ Expander/ Breast Implants SILTEX™ ROUND BECKER™ 25 EXPANDER/IMPLANTS, COHESIVE I™ (25% Silicone Gel, Cohesive I™, in outer lumen, 75% Saline in inner lumen) temporary overexpansion volumes Volume cc Gel Volume cc Max Saline cc Total Gel- Saline cc Total Saline cc Total Gel- Saline cc Diameter cm Proj. cm Cat.# 150 40 185 225 85-150 125-190 10,7 2,4 354-1500 200 50 250 300 125-200 175-250 11,6 2,7 354-2000 250 60 315 375 165-255 225-315 12,1 3,0 354-2500 300 75 375 450 200-300 275-375 12,9 3,0 354-3000 350 90 435 525 235-350 325-440 14,1 3,0 354-3500 400 100 500 600 275-400 375-500 13,9 3,4 354-4000 500 125 625 750 350-500 475-625 14,7 3,7 354-5000 600 150 750 900 425-600 575-750 15,6 4,2 354-6000 700 175 875 1050 500-700 675-875 16,8 4,3 354-7000 800 200 1000 1200 575-800 775-1000 17,2 4,6 354-8000 Note: Individual implant dimensions may vary slightly in products of this type. Not all units will conform exactly to the dimensions noted above - 32 - Expanders SILTEX™ CONTOUR PROFILE™ BECKER™ 35 Expander/Implants, Cohesive II™ (35% Silicone Gel, Cohesive II™, in outer lumen, 65% Saline in inner lumen) temporary overexpansion volumes Volume cc Gel Volume cc Max Saline cc Total Gel- Saline cc Total Saline cc Total Gel- Saline cc Width cm Height cm Proj. cm Cat.# MENTOR® BECKER™ Expander/ Breast Implants Note: Individual implant dimensions may vary slightly in products of this type. Not all units will conform exactly to the dimensions noted above - 33 - Expanders - 34 - Smooth Round Tissue Expanders Device Volume cc Diameter cm Projection cm Catalog # 400 11,3 5,9 350-4305M 550 13,4 5,8 350-4307M 700 14,6 6,7 350-4304M 850 15,0 7,2 350-4308M 1000 15,5 7,8 350-4306M Smooth Elliptical Tissue Expanders temporary overexpansion Device Volume cc Length cm Width cm Nominal Projection cm Proj. cm Max. Volume cc Catalog # 25 6,0 4,0 2,3 4,5 75 350-5301M breast augmentation dubai breast enlargement dubai breast implants dubai breast surgery dubai non surgical breast augmentation dubai breast surgery in uae boob job dubai Projection cm Catalog # Smooth Crescent Tissue Expanders Device Volume cc Length cm Width cm Projection cm Catalog # Other Tissue Expanders Expanders - 36 - Accessories Injection Port Detector Description CENTERSCOPE™ Magnetic Detection Device Injection Dome Description Dome Pack Set Can be used with SPECTRUM™ Shaped Adjustable Saline Breast Implant, Round BECKER™ Expander/Breast Implant, and Smooth Tissue Expanders 350-DOMPK Catalog # Catalog # 350-4402 Expanders - 37 - Other Round Saline Breast Implants Smooth Round Breast Implants, Moderate Profile NOMINAL FILL MAXIMUM FILL Volume cc Diameter cm Projection cm Volume cc Diameter cm Projection cm Catalog # Sterile Saline Sizerι 125 9,5 3,0 150 9,1 3,4 350-1610 351-125SZ 150 10,0 3,1 175 9,6 3,7 350-1615 175 10,6 3,3 200 10,0 3,9 350-1620 351-175SZ 200 11,0 3,4 225 10,4 3,9 350-1625 225 11,5 3,5 250 10,9 4,0 350-1630 351-225SZ 250 11,9 3,6 275 11,2 4,1 350-1635 275 12,3 3,7 300 11,7 4,2 350-1640 351-275SZ 300 12,6 3,7 325 12,1 4,3 350-1645 325 13,0 3,8 375 12,3 4,5 350-1650 351-325SZ 350 13,3 3,9 400 12,6 4,7 350-1655 375 13,6 4,0 425 12,8 4,8 350-1660 351-375SZ 425 14,2 4,1 475 13,5 4,9 350-1670 351-425SZ 475 14,8 4,2 525 14,2 4,9 350-1680 351-475SZ 525 15,0 4,2 575 14,5 5,1 350-1685 575 15,0 4,5 625 14,8 5,1 350-1690 625 15,2 4,6 700 14,9 5,6 350-1695 700 15,6 4,9 775 14,9 5,8 350-1697 Saline Breast Implants - 38 - ι Single Use Only Note: Individual implant dimensions may vary slightly in products of this type. Not all units will conform exactly to the dimensions noted above Other Saline Breast Implants Smooth Round Breast Implants, Moderate Plus Profile NOMINAL FILL MAXIMUM FILL Volume cc Diameter cm Projection cm Volume cc Diameter cm Projection cm Catalog # Sterile Saline Sizerι - 39 - ι Single Use Only Note: Individual implant dimensions may vary slightly in products of this type. Not all units will conform exactly to the dimensions noted above Other Smooth Round Breast Implants, High Profile NOMINAL FILL MAXIMUM FILL Volume cc Diameter cm Projection cm Volume cc Diameter cm Projection cm Catalog # Sterile Saline Sizerι Saline Breast Implants - 40 - Other Saline Breast Implants - 41 - SPECTRUM™ Adjustable Saline Breast Implants Smooth Round SPECTRUM™ Implants NOMINAL FILL MAXIMUM FILL Temp. Volume cc Min. Volume cc Final Volume cc Diameter cm Projection cm Final Volume cc Diameter cm Projection cm Catalog # SILTEX™ CONTOUR PROFILE™ SPECTRUM™ Implants NOMINAL FILL MAXIMUM FILL Temp. Volume cc Min. Volume cc Final Volume cc Width cm Height cmbreast augmentation dubai breast enlargement dubai breast implants dubai breast surgery dubai non surgical breast augmentation dubai breast surgery in uae boob job dubaiProj. cm Final Volume cc Width cm Height cm Proj. cm Catalog # 275 235 275 11,5 9,5 5,1 330 11,1 9,4 6,3 354-2511 350 300 350 12,3 10,5 5,3 420 11,9 10,1 6,9 354-2512 450 380 450 13,2 11,0 6,1 540 12,7 11,0 7,5 354-2513 550 470 550 14,0 11,9 6,4 660 13,7 11,9 7,9 354-2514 650 550 650 15,0 12,7 6,6 780 14,5 12,5 8,2 354-2515 Other Sterile Resterilizable Gel Breast Implants Sizersε - 42 - Other Sterile Resterilizable Gel Breast Implants Sizersε ε Resterilizable up to 10 times. Note: Individual implant dimensions may vary slightly in products of this type. Not all units will conform exactly to the dimensions noted above Round Gel Breast Implant Sizers, Moderate Plus Profileε Volume cc Diameter cm Projection cm Catalog # 125 8,9 2,8 RSZ-1251 150 9,5 2,9 RSZ-1501 175 10,0 3,1 RSZ-1751 200 10,5 3,2 RSZ-2001 225 10,9 3,3 RSZ-2251 250 11,3 3,4 RSZ-2501 275 11,7 3,5 RSZ-2751 300 12,0 3,6 RSZ-3001 325 12,3 3,8 RSZ-3251 350 12,5 3,9 RSZ-3501 375 12,8 4,0 RSZ-3751 400 13,1 4,0 RSZ-4001 450 13,6 4,2 RSZ-4501 500 14,1 4,3 RSZ-5001 550 14,6 4,5 RSZ-5501 600 15,0 4,6 RSZ-6001 700 15,8 4,9 RSZ-7001 800 16,5 5,1 RSZ-8001 - 43 - Other - 44 - Sterile Resterilizable Gel Breast Implants Sizersε Round Gel Breast Implant Sizers, High Profile Volume cc breast augmentation dubai breast enlargement dubai breast implants dubai breast surgery dubai non surgical breast augmentation dubai breast surgery in uae boob job dubai cm Projection cm Catalog # 125 8,3 3,5 RSZ-1254 150 8,8 3,7 RSZ-1504 175 9,3 3,9 RSZ-1754 200 9,7 4,0 RSZ-2004 225 10,1 4,2 RSZ-2254 250 10,5 4,3 RSZ-2504 275 10,8 4,4 RSZ-2754 300 11,1 4,5 RSZ-3004 325 11,4 4,6 RSZ-3254 350 11,7 4,8 RSZ-3504 375 12,0 4,8 RSZ-3754 400 12,2 5,0 RSZ-4004 425 12,5 5,0 RSZ-4254 450 12,8 5,1 RSZ-4504 500 13,2 5,3 RSZ-5004 550 13,6 5,5 RSZ-5504 600 14,0 5,6 RSZ-6004 650 14,4 5,7 RSZ-6504 700 14,8 5,8 RSZ-7004 800 15,5 6,0 RSZ-8004 ε Resterilizable up to 10 times. Note: Individual implant dimensions may vary slightly in products of this type. Not all units will conform exactly to the dimensions noted above Other - 45 - Sterile Resterilizable Gel Breast Implants Sizersε Round Gel Breast Implant Sizers, Ultra High Profile Volume cc Diameter cm Projection cm Catalog # 135 7,8 4,1 RSZ-5135 160 8,2 4,3 RSZ-5160 185 8,4 4,4 RSZ-5185 215 8,7 4,5 RSZ-5215 240 9,0 4,7 RSZ-5240 270 9,3 4,8 RSZ-5270 295 9,7 5,0 RSZ-5295 320 9,8 5,1 RSZ-5320 350 10,1 5,2 RSZ-5350 375 10,4 5,3 RSZ-5375 400 10,6 5,4 RSZ-5400 430 10,9 5,6 RSZ-5430 455 11,2 5,7 RSZ-5455 480 11,4 5,8 RSZ-5480 535 12,0 6,1 RSZ-5535 590 12,5 6,3 RSZ-5590 ε Resterilizable up to 10 times. Note: Individual implant dimensions may vary slightly in products of this type. Not all units will conform exactly to the dimensions noted above Other ε Resterilizable up to 10 times. Note: Individual implant dimensions may vary slightly in products of this type. Not all units will conform exactly to the dimensions noted above Round Moderate Plus Profile Xtra Sterile Resterilizable Gel Breast Implant Sizers (for textured implants) Volume cc Diameter cm Projection cm Catalog # 130 8,9 3,1 RSZMPX130 160 9,5 3,3 RSZMPX160 190 10,0 3,4 RSZMPX190 215 10,4 3,6 RSZMPX215 240 10,8 3,7 RSZMPX240 270 11,4 3,8 RSZMPX270 295 11,5 4,0 RSZMPX295 325 11,9 4,1 RSZMPX325 350 12,3 4,1 RSZMPX350 370 12,6 4,1 RSZMPX370 405 12,7 4,4 RSZMPX405 440 13,1 4,5 RSZMPX440 490 13,6 4,7 RSZMPX490 545 14,0 4,9 RSZMPX545 605 14,5 5,1 RSZMPX605 645 14,9 5,1 RSZMPX645 755 15,7 5,4 RSZMPX755 Sterile Resterilizable Gel Breast Implants Sizersε - 46 - Other Sterile Resterilizable Gel Breast Implants Sizersε ε Resterilizable up to 10 times. Note: Individual implant dimensions may vary slightly in products of this type. Not all units will conform exactly to the dimensions noted above Round Moderate Plus Profile Xtra Sterile Resterilizable Gel Breast Implant Sizers (for smooth implants) Volume cc Diameter cm Projection cm Catalog # 130 8,9 3,1 RSZMPX130 160 9,5 3,3 RSZMPX160 190 10,0 3,4 RSZMPX190 215 10,4 3,6 RSZMPX215 240 10,8 3,7 RSZMPX240 270 11,4 3,8 RSZMPX270 295 11,5 4,0 RSZMPX295 325 11,9 4,1 RSZMPX325 350 12,3 4,1 RSZMPX350 370 12,6 4,1 RSZMPX370 405 12,7 4,4 RSZMPX405 440 13,1 4,5 RSZMPX440 490 13,6 4,7 RSZMPX490 545 14,0 4,9 RSZMPX545 605 14,5 5,1 RSZMPX605 645 14,9 5,1 RSZMPX645 755 15,7 5,4 RSZMPX755 - 47 - Other - 48 - ε Resterilizable up to 10 times. Note: Individual implant dimensions may vary slightly in products of this type. Not all units will conform exactly to the dimensions noted above Round High Profile Xtra Sterile Resterilizable Gel Breast Implant Sizers (for textured implants) Volume cc Diameter breast augmentation dubai breast enlargement dubai breast implants dubai breast surgery dubai non surgical breast augmentation dubai breast surgery in uae boob job dubai cm Catalog # 150 8,3 4,1 RSZTHPX150 180 8,8 4,4 RSZTHPX175 200 9,2 4,5 RSZTHPX200 235 9,5 4,9 RSZTHPX230 260 9,9 5,0 RSZ-HPX255 285 10,3 5,0 RSZ-HPX285 335 10,7 5,4 RSZTHPX325 355 11,0 5,5 RSZTHPX340 380 11,3 5,5 RSZ-HPX365 415 11,5 5,8 RSZTHPX405 450 11,9 5,9 RSZTHPX425 465 12,1 5,8 RSZTHPX455 490 12,5 5,8 RSZTHPX470 535 12,7 6,0 RSZTHPX515 595 13,1 6,3 RSZTHPX570 650 13,5 6,5 RSZTHPX620 700 14,1 6,5 RSZTHPX680 755 14,4 6,7 RSZTHPX725 790 14,8 6,7 RSZTHPX765 Sterile Resterilizable Gel Breast Implants Sizersε Other - 49 - Sterile Resterilizable Gel Breast Implants Sizersε ε Resterilizable up to 10 times. Note: Individual implant dimensions may vary slightly in products of this type. Not all units will conform exactly to the dimensions noted above Round High Profile Xtra Sterile Resterilizable Gel Breast Implant Sizers (for smooth implants) Volume cc Diameter cm Projection cm Catalog # 150 8,3 4,1 RSZSHPX150 180 8,8 4,4 RSZSHPX180 200 9,2 4,5 RSZSHPX200 235 9,5 4,9 RSZSHPX235 260 9,9 5,0 RSZSHPX260 285 10,3 5,0 RSZSHPX285 335 10,7 5,4 RSZSHPX335 355 11,0 5,5 RSZSHPX355 380 11,3 5,5 RSZSHPX380 415 11,5 5,8 RSZSHPX415 450 11,9 5,9 RSZSHPX450 465 12,1 5,8 RSZSHPX465 490 12,5 5,8 RSZSHPX490 535 12,7 6,0 RSZSHPX535 595 13,1 6,3 RSZSHPX595 650 13,5 6,5 RSZSHPX650 700 14,1 6,5 RSZSHPX700 755 14,4 6,7 RSZSHPX755 790 14,8 6,7 RSZSHPX790 Other - 50 - Sterile Resterilizable Gel Breast Implants Sizersε CPG™ GEL BREAST IMPLANT SIZERS CPG™ Implant Sizers 331, Cohesive III™, Tall Height, Moderate Projection Volume cc Width cm Height cm Projection cm Lower Pole Arc A-B (cm) Catalog # 125 9,0 9,2 3,2 7,3 RSZ-0903 150 9,5 9,7 3,3 7,7 RSZ-0953 175 10,0 10,2 3,4 8,1 RSZ-1003 200 10,5 10,7 3,5 8,4 RSZ-1053 230 11,0 11,3 3,6 8,8 RSZ-1103 265 11,5 11,8 3,7 9,1 RSZ-1153 300 12,0 12,3 3,9 9,5 RSZ-1203 340 12,5 12,8 4,0 9,9 RSZ-1253 380 13,0 13,3 4,1 10,2 RSZ-1303 425 13,5 13,8 4,3 10,6 RSZ-1353 475 14,0 14,3 4,5 11,0 RSZ-1403 530 14,5 14,8 4,6 11,3 RSZ-1453 585 15,0 15,3 4,0 11,7 RSZ-1503 645 15,5 15,9 5,0 12,1 RSZ-1553 CPG™ Implant Sizers 321, Cohesive III™, Medium Height, Moderate Projection Volume cc Width cm Height cm Projection cm Lower Pole Arc A-B (cm) Catalog # 120 9,0 8,5 3,3 7,0 RSZ-0908 135 9,5 8,9 3,5 7,3 RSZ-0958 155 10,0 9,4 3,7 7,7 RSZ-1008 180 10,5 9,9 3,8 8,0 RSZ-1058 215 11,0 10,3 3,9 8,2 RSZ-1108 245 11,5 10,8 4,0 8,6 RSZ-1158 280 12,0 11,3 4,2 8,9 RSZ-1208 315 12,5 11,8 4,4 9,2 RSZ-1258 355 13,0 12,2 4,6 9,6 RSZ-1308 395 13,5 12,7 4,7 9,9 RSZ-1358 440 14,0 13,2 4,9 10,3 RSZ-1408 480 14,5 13,6 5,0 10,5 RSZ-1458 530 15,0 14,1 5,2 10,9 RSZ-1508 640 16,0 15,0 5,6 11,5 RSZ-1608 775 17,0 16,0 5,9 12,2 RSZ-1708 ε Resterilizable up to 10 times. Note: Individual implant dimensions may vary slightly in products of this type. Not all units will conform exactly to the dimensions noted above Other - 51 - Sterile Resterilizable Gel Breast Implants Sizersε CPG™ Implant Sizers 311, Cohesive III™, Low Height, Moderate Projection Volume cc Width cm Height cm Projection cm Lower Pole Arc A-B (cm) Catalog # 120 9,5 8,5 3,2 6,9 RSZ-0095 140 10,0 8,9 3,4 7,2 RSZ-0100 160 10,5 9,4 3,6 7,5 RSZ-0105 180 11,0 9,8 3,7 7,9 RSZ-0110 210 11,5 10,3 3,9 8,2 RSZ-0115 235 12,0 10,7 4,1 8,5 RSZ-0120 270 12,5 11,2 4,2 8,8 RSZ-0125 300 13,0 11,6 4,4 9,2 RSZ-0130 335 13,5 12,0 4,6 9,5 RSZ-0135 375 14,0 12,5 4,7 9,8 RSZ-0140 415 14,5 12,9 4,9 10,1 RSZ-0145 460 15,0 13,4 5,1 10,5 RSZ-0150 510 15,5 13,8 5,2 10,8 RSZ-0155 560 16,0 14,3 5,4 11,1 RSZ-0160 615 16,5 14,7 5,6 11,4 RSZ-0165 ε Resterilizable up to 10 times. Note: Individual implant dimensions may vary slightly in products of this type. Not all units will conform exactly to the dimensions noted above Other - 52 - Sterile Resterilizable Gel Breast Implants Sizersε CPG™ GEL BREAST IMPLANT SIZERS CPG™ Implant Sizers 332, Cohesive III™, Tall Height, Moderate Plus Projection Volume cc Width cm Height cm Projection cm Lower Pole Arc A-B (cm) Catalog # 145 9,0 9,4 3,8 8,1 RSZ-0909 175 9,5 9,9 4,0 8,5 RSZ-0959 205 10,0 10,4 4,2 8,9 RSZ-1009 235 10,5 10,9 4,4 9,3 RSZ-1059 270 11,0 11,5 4,7 9,7 RSZ-1109 305 11,5 12,0 4,9 10,1 RSZ-1159 350 12,0 12,5 5,1 10,5 RSZ-1209 395 12,5 13,0 5,3 10,9 RSZ-1259 455 13,0 13,5 5,5 11,3 RSZ-1309 495 13,5 14,1 5,7 11,7 RSZ-1359 555 14,0 14,6 5,9 12,1 RSZ-1409 615 14,5 15,1 6,1 12,6 RSZ-1459 680 15,0 15,6 6,3 13,0 RSZ-1509 CPG™ Implant Sizers 322, Cohesive III™, Medium Height, Moderate Projection Volume cc Width cm Height cm Projection cm Lower Pole Arc A-B (cm) Catalog # 140 9,0 8,5 3,8 7,6 RSZ-0905 165 9,5 8,9 4,0 8,0 RSZ-0955 195 10,0 9,4 4,2 8,4 RSZ-1005 225 10,5 9,9 4,4 8,8 RSZ-1055 255 11,0 10,3 4,7 9,2 RSZ-1105 295 11,5 10,8 4,9 9,5 RSZ-1155 330 12,0 11,3 5,1 9,9 RSZ-1205 375 12,5 11,8 5,3 10,3 RSZ-1255 420 13,0 12,2 5,5 10,7 RSZ-1305 475 13,5 12,7 5,7 11,1 RSZ-1355 525 14,0 13,2 5,9 11,4 RSZ-1405 585 14,5 13,6 6,1 11,8 RSZ-1455 650 15,0 14,1 6,3 12,2 RSZ-1505 ε Resterilizable up to 10 times. Note: Individual implant dimensions may vary slightly in products of this type. Not all units will conform exactly to the dimensions noted above Other - 53 - Sterile Resterilizable Gel Breast Implants Sizersε CPG™ Implant Sizers 312, Cohesive III™, Low Height, Moderate Projection Volume cc Width cm Height cm Projection cm Lower Pole Arc A-B (cm) Catalog # 125 9,0 8,0 3,8 7,2 RSZ-0907 145 9,5 8,4 4,0 7,5 RSZ-0957 170 10,0 8,8 4,2 7,9 RSZ-1007 195 10,5 9,3 4,4 8,3 RSZ-1057 225 11,0 9,7 4,7 8,6 RSZ-1107 255 11,5 10,2 4,9 9,0 RSZ-1157 290 12,0 10,6 5,1 9,3 RSZ-1207 330 12,5 11,1 5,3 9,7 RSZ-1257 370 13,0 11,5 5,5 10,0 RSZ-1307 415 13,5 11,9 5,7 10,4 RSZ-1357 465 14,0 12,4 5,9 10,8 RSZ-1407 515 14,5 12,8 6,1 11,1 RSZ-1457 570 15,0 13,3 6,3 11,5 RSZ-1507 690 16,0 14,2 6,8 12,2 RSZ-1607 ε Resterilizable up to 10 times. Note: Individual implant dimensions may vary slightly in products of this type. Not all units will conform exactly to the dimensions noted above Other - 54 - CPG™ Implant Sizers 323, Cohesive III™, Medium Height, High Projection Volume cc Width cm Height cm Projection cm Lower Pole Arc A-B (cm) Catalog # 165 9,0 8,5 4,6 8,1 RSZ-0902 195 9,5 8,9 4,8 8,5 RSZ-0952 225 10,0 9,4 5,1 8,9 RSZ-1002 260 10,5 9,9 5,3 9,3 RSZ-1052 300 11,0 10,3 5,6 9,7 RSZ-1102 345 11,5 10,8 5,8 10,1 RSZ-1152 390 12,0 11,3 6,0 10,5 RSZ-1202 440 12,5 11,8 6,2 10,9 RSZ-1252 495 13,0 12,2 6,5 11,3 RSZ-1302 555 13,5 12,7 6,7 11,8 RSZ-1352 620 14,0 13,2 6,9 12,2 RSZ-1402 685 14,5 13,6 7,1 12,6 RSZ-1452 CPG™ Implant Sizers 333, Cohesive III™, Tall Height, High Projection Volume cc Width cm Height cm Projection cm Lower Pole Arc A-B (cm) Catalog # 180 9,0 9,4 4,6 8,4 RSZ-4090 215 9,5 9,9 4,8 8,8 RSZ-4095 250 10,0 10,4 5,1 9,3 RSZ-4100 290 10,5 10,9 5,3 9,7 RSZ-4105 330 11,0 11,5 5,6 10,1 RSZ-4110 380 11,5 12,0 5,8 10,5 RSZ-4115 430 12,0 12,5 6,0 11,0 RSZ-4120 485 12,5 13,0 6,2 11,4 RSZ-4125 545 13,0 13,5 6,5 11,8 RSZ-4130 610 13,5 14,1 6,7 12,2 RSZ-4135 680 14,0 14,6 6,9 12,7 RSZ-4140 755 14,5 15,1 7,1 13,1 RSZ-4145 ε Resterilizable up to 10 times. Note: Individual implant dimensions may vary slightly in products of this type. Not all units will conform exactly to the dimensions noted above Sterile Resterilizable Gel Breast Implants Sizersε CPG™ GEL BREAST IMPLANT SIZERS Other - 55 - CPG™ Implant Sizers 313, Cohesive III™, Low Height, High Projection Volume cc Width cm Height cm Projection cm Lower Pole Arc A-B (cm) Catalog # 130 9,0 8,1 4,4 7,6 RSZ-0906 155 9,5 8,6 4,5 7,8 RSZ-0956 180 10,0 9,0 4,6 8,3 RSZ-1006 210 10,5 9,5 4,8 8,7 RSZ-1056 240 11,0 9,9 4,9 9,1 RSZ-1106 270 11,5 10,3 5,0 9,5 RSZ-1156 310 12,0 10,8 5,2 9,9 RSZ-1206 350 12,5 11,2 5,4 10,2 RSZ-1256 395 13,0 11,7 5,6 10,6 RSZ-1306 440 13,5 12,2 5,8 11,0 RSZ-1356 490 14,0 12,6 6,1 11,4 RSZ-1406 545 14,5 13,1 6,3 11,7 RSZ-1456 605 15,0 13,5 6,6 12,1 RSZ-1506 ε Resterilizable up to 10 times. Note: Individual implant dimensions may vary slightly in products of this type. Not all units will conform exactly to the dimensions noted above Sterile Resterilizable Gel Breast Implants Sizersε Other Sterile Saline Breast Implant Sizers Round Saline Breast Implant Sizers, Moderate Profile NOMINAL FILL MAXIMUM FILL Volume cc Diameter cm Projection cm Volume cc Diameter cm Projection cm Catalog # 125 9,5 3,0 150 9,1 3,4 351-125SZ 175 10,6 3,3 200 10,0 3,9 351-175SZ 225 11,5 3,5 250 10,9 4,0 351-225SZ 275 12,3 3,7 300 11,7 4,2 351-275SZ 325 13,0 3,8 375 12,3 4,5 351-325SZ 375 13,6 4,0 425 12,8 4,8 351-375SZ 425 14,2 4,1 475 13,5 4,9 351-425SZ 475 14,8 4,2 525 14,2 4,9 351-475SZ Round Saline Breast Implant Sizers, Moderate Plus Profile NOMINAL FILL MAXIMUM FILL Volume cc Diameter cm Projection cmbreast augmentation dubai breast enlargement dubai breast implants dubai breast surgery dubai non surgical breast augmentation dubai breast surgery in uae boob job dubaiVolume cc Diameter cm Projection cm Catalog # 175 9,5 3,5 210 9,3 4,2 351-2175SZ 200 10,0 3,7 240 9,7 4,4 351-2200SZ 225 10,4 3,8 270 10,1 4,6 351-2225SZ 250 10,8 4,0 300 10,5 4,7 351-2250SZ 275 11,0 4,1 330 10,8 4,9 351-2275SZ 300 11,5 4,3 360 11,2 5,0 351-2300SZ 325 11,9 4,4 390 11,5 5,2 351-2325SZ 350 12,1 4,5 420 11,7 5,3 351-2350SZ 375 12,3 4,6 450 12,0 5,4 351-2375SZ 400 12,6 4,7 480 12,3 5,5 351-2400SZ 425 12,9 4,8 510 12,5 5,6 351-2425SZ 450 13,0 4,9 540 12,8 5,7 351-2450SZ 475 13,3 5,0 570 13,0 5,8 351-2475SZ 500 13,6 5,1 600 13,2 5,9 351-2500SZ 550 14,0 5,3 660 13,7 6,1 351-2550SZ 600 14,5 5,5 720 14,1 6,3 351-2600SZ 650 14,8 5,6 780 14,4 6,5 351-2650SZ 700 15,2 5,8 840 14,8 6,6 351-2700SZ 750 15,6 5,9 900 15,1 6,8 351-2750SZ 800 16,1 6,0 960 15,5 7,0 351-2800SZ Other - 57 - Sterile Saline Breast Implant Sizers CONTOUR PROFILE™ Saline Breast Implant Sizers, High Profile Volume cc Width cm Height cm Projection cm Catalog # 275 + 25 11,5 9,5 5,1 351-0711SZ 350 + 50 12,3 10,5 5,3 351-0712SZ 450 + 50 13,2 11,0 6,1 351-0713SZ 550 + 50 14,0 11,9 6,4 351-0714SZ 650 + 75 15,0 12,7 6,6 351-0715SZ Round Saline Breast Implant Sizers, High Profile NOMINAL FILL MAXIMUM FILL Volume cc Diameter cm Projection cm Volume cc Diameter cm Projection cm Catalog # 190 9,3 4,1 225 9,1 5,1 351-3190SZ 230 10,0 4,3 275 9,8 5,5 351-3230SZ 270 10,4 4,6 325 10,2 5,8 351-3270SZ 290 10,8 4,7 350 10,5 5,9 351-3290SZ 310 11,0 4,8 375 10,7 6,0 351-3310SZ 330 11,3 4,8 400 11,0 6,2 351-3330SZ 380 11,7 5,2 450 11,4 6,4 351-3380SZ 420 12,0 5,4 500 11,7 6,7 351-3420SZ 500 12,8 5,6 600 12,4 7,1 351-3500SZ 630 13,8 5,9 750 13,4 7,4 351-3630SZ Note: Individual implant dimensions may vary slightly in products of this type. Not all units will conform exactly to the dimensions noted above - 58 - References 1. Based on warranty comparisons of the following breast implants: Allergan Natrelle: http://www.natrelle.co.uk/breast-enhancement/Pages/ warranty.aspx, EuroSilicone & Nagor: http://nagor.com/pdf/Warranty_ PDF_Nagor.pdf, Arion: http:// www.laboratoires-arion.com images/ arion/ ARION_GUARANTEE_PROGRAM_ANG.pdf, Polytech: http://www.polytechhealth. info/ images/pdf/IoE_ Information_engl_2015- 01.pdf, Motiva: https:// motivaimplants.com/productwarranty/Sebbin: Garantie des IMPLANTS MAMMAIRES and La garantie premium, Accessed March 20 2017. 2. Mentor Worldwide, LLC. MemoryShape® Post-Approval Cohort Study (formerly Contour Profile Gel Core Study) Final Clinical Study Report. 02 June 2015 Mentor Worldwide LLC. Data on File. MemoryGel® Core Gel Clinical Study Final Report, April 2013. Maxwell, G. Patrick; Van Natta, Bruce W.; Bengtson, Bradley P.; and Murphy, Diane K., «Ten-Year Results From the Natrelle 410 Anatomical Form-Stable Silicone Breast Implant Core Study» (2015). Public Health Resources. Health Canada: Summary Basis of Decision (SBD) for Natrelle™ Highly Cohesive Silicone-Filled Breast Implants. Application No. 88573. License No.72262. Date Issued: 2014/01/17. Health Canada: Summary Basis of Decision (SBD) for Natrelle™ Silicone-Filled Breast Implants-Smooth Shell With Barrier and Narelle(TM) Silicone Filled Breast Implants - Textured Shell with Barrier Layer. Application No. 61865 and 60524 License No License No 72264 and 72263. Date Issued: 2012/09/25. 3. Danino, A. M., Basmacioglu, P., Saito, S., Rocher, F., Blanchet-Bardon, C., Revol, M., & Servant, J. M. (2001). Comparison of the capsular response to the Biocell RTV and Mentor 1600 Siltex breast implant surface texturing: a scanning electron microscopic study. Plastic and reconstructive surgery, 108(7), 2047-2052. - 59 - 4. Mentor Worldwide, LLC. MemoryShape® Post-Approval Cohort Study (formerly Contour Profile Gel Core Study) Final Clinical Study Report. 02 June 2015 5. Health Canada: Summary Basis of Decision (SBD) for Natrelle™ Highly Cohesive Silicone-Filled Breast Implants. Application No. 88573. License No.72262. Date Issued: 2014/01/17. 6. Maxwell, G. Patrick, et al. «Ten-year results from the Natrelle 410 anatomical form-stable silicone breast implant core study.» Aesthetic Surgery Journal 35.2 (2015): 145-155. 7. Hoffman_CP529_530Interim_Report_for_CP529_DOF_PR_20131007 (PDF pg. 2) 8. Mentor Worldwide LLC, Data on File, HS820.050331.02F Validation Case Study Report: Market Acceptance of the Contour Profile Gel Product Family - TX.820.081125.01 9. As compared to the CONTOUR PROFILE® Tissue Expanders at 5 mm. Data on file at Mentor Worldwide LLC. 10. Mentor Consumer Preference Market Research Report – July 2017. 11. Product Dimensions for MemoryGel™ and MemoryGel™ Xtra Breast Implants Mentor R&D Benchtop Testing (Pinch Test) - July 2017. Important Safety Information MENTOR® Breast Implants are indicated for breast augmentation, in women who are at least 18 years old, or for breast reconstruction. Breast implant surgery should not be performed in women with active infection anywhere in their body, with existing cancer or pre-cancer of their breast(s) who have not received adequate treatment for those conditions or who are pregnant or nursing. There are risks associated with breast implant surgery. Breast implants are not lifetime devices and breast implantation is not necessarily a one-time surgery. The most common complications with MENTOR® MemoryGel™ Breast Implants include re-operation, implant removal, capsular contracture, asymmetry, and breast pain. A lower risk of complication is implant rupture, which is most often silent. The health consequences of a ruptured silicone gel-filled breast implant have not been fully established. Screenings such as mammography, MRI, or ultrasound are recommended after initial implant surgery to assist in detecting implant rupture. The most common complications with MENTOR® Saline-Filled Implants include re-operation, implant removal, capsular contracture, wrinkling, deflation, asymmetry, and breast pain. MENTOR® CPX™4 Breast Tissue Expanders can be utilized for breast reconstruction after mastectomy, correction of an underdeveloped breast, scar revision and tissue defect procedures. These expanders are intended for temporary subcutaneous or submuscular implantation.* CONTOUR PROFILE™ Tissue Expanders are devices that contain magnetic injection domes and are NOT MRI compatible. Do not use the CONTOUR PROFILE™ Tissue Expander in patients where an MRI may be needed. DO NOT use the CONTOUR PROFILE™ Tissue Expander in patients that have a previously - 60 - implanted device that could be affected by a magnetic field. The device could be moved by the MRI causing pain or displacement, potentially resulting in a revision surgery. The incidence of extrusion of the expander has been shown to increase when the expander has been placed in injured areas: scarred, heavily irradiated or burned tissue, crushed bone areas or where severe surgical reduction of the area has previously been performed. Your patient needs to be informed and understand the risks and benefits of breast implants, and provided with an opportunity to consult with you prior to deciding on surgery. For detailed indications, contraindications, warning and precautions associated with the use of all MENTOR® Implantable Devices, please refer to the Product Insert Data Sheet provided with each product, or review the Important Safety Information provided at www.mentorwwllc.eu. - 61 - Mentor Worldwide LLC 33 Technology Drive Irvine, CA 92618, USA Tel: +1 8006368678 www.mentorwwlc.eu FAQ: Breast Augmentation What is a breast augmentation? A breast augmentation involves putting breast implants in your chest to enhance your natural breast tissue and make your breasts fuller and larger. What type of implants are there? Dr. Coon uses silicone implants made by Mentor. There are different profiles available. You will be able to see the implants during your consultation and you and the surgeon will determine what profile is best for your body. Can I try on the implants to know what size I want? During your consultation, you will be able to “try on” some implant samples to inform the surgical team with approximate sizes. Please bring a cami tank top to aid in this process. Where are the implants placed? There are two locations that an implant can be placed, either above or below the muscle. You and your surgeon will talk about what the best surgical option is for your body. What determines the size of the implants? This is a conversation you and your surgeon will have to determine what size is best for your body frame. It is important to keep in mind that skin stretching may limit the size of the implant. Where is the incision? There will be a small surgical incision made underneath the breast where we insert the implant. This incision is typically hidden under the natural fold of the breast and is hardly noticeable. How long is the surgery? On average, the surgery takes 2-4 hours. Will I be in a lot of pain after surgery? You may experience some discomfort for a few days after surgery, but generally 4-5 days after surgery you will be able to return to your normal activities. Will I have surgical drains? No, this procedure does not require you to go home with any drains. What dressings will I go home with after surgery? You will go home with steri strips over the incision line and a large clear band aid, called tegaderm. This dressing will be removed 2 week after surgery during your post-operative visit with clinical staff. FAQ: Breast Augmentation Can I shower after surgery? You may begin showering the day after surgery. Do not scrub at your incision line or remove the dressing placed in the operating room. What bra can I wear after surgery? After surgery you will be given a special bra that you must continue to wear for 3 weeks. This bra will be provided by the hospital and placed on you in the operating room. After 3 weeks, you may begin wearing a sports bra or a soft cloth bra – you should NOT wear an underwire bra for at least 6 weeks after surgery. What limitations do I have after surgery? For 4 weeks after surgery, you should not lift your hands over your head. You should also not push, pull, or lift anything greater than 5 pounds during these 4 weeks. Am I required to do implant exercises after surgery? Yes, you should begin performing implant exercises twice a day starting 5 days after surgery. You should continue these exercises for 3 months after your surgery date. Each breast should be gently pushed up, to the left, and to the right and held for a few seconds. These exercise helps to prevent capsular contractions, which is a pocket around the breast that keep the implant from freely moving. There are more details available in your post-op instructions, which you will receive prior to your surgery. When can I begin scar therapy? You can begin scar therapy approximately 8 weeks after surgery. You can start simply with scar massage, which involves using shea or cocoa butter and gently massaging the scar. If you feel like you need additional scar care, you can use creams, such as Mederma, or silicone-based gels. Remember, it can take up to 18 months for a scar to fully mature and fade. Is there any long term follow-up need after surgery? It is recommended by the FDA that patients with silicone implants should receive a MRI 3 years post-operatively and every 2 years after. Despite recent news, there is no apparent association between silicone gel-filled breast implants and connective tissue disease or breast cancer. G C H A P T E R 54 The dual plane approach to breast augmentation Steven Teitelbaum History The breast implant pocket choice has a profound effect on the appearance of the augmented breast. Along with the selection of the device itself, it is the most important preoperative decision. Critical manifestations of this choice may not be apparent for many years, as some effects of the implant on the soft tissue occur gradually yet inexorably. The most commonly described pocket locations are: (1) total submuscular (subserratus and subpectoral); (2) partial retropectoral (behind the pectoralis with its origins from the ribs left intact); (3) subfascial (between the pectoralis muscle fascia and the pectoralis muscle); (4) submammary or subglandular (between the breast and the pectoralis fascia). Total submuscular is more frequently a reconstructive technique, less commonly done for augmentation owing to a more painful and bloody dissection, a tendency for the device to rise superiorly, and diffi culty in predictably creating a deep and well-formed inframammary fold. Subfascial has not been widely adopted due to an absence of satisfactorily controlled or long-term data. With scarcely 0.5 – 1 mm more coverage than a classic submammary dissection, this procedure is only a minor variation of the submammary pocket and does not qualify as a distinct pocket type. Partial retropectoral and submammary are the most popular methods. Proponents of each are quick to point out the distinct advantages of their technique and the disadvantages of the other. These comments are frequently appropriate. But these comments are not equally applicable to all situations. There are indeed breast types for which the benefi ts and drawbacks of one pocket makes it the better choice. Even so, some shortcomings of that preferred pocket frequently remain at issue. The dual plane as fi rst published by John Tebbetts in 2001 is the ideal compromise, in that it allows the implant to be simultaneously retropectoral where the device most needs coverage, and retromammary where it most needs to be in direct apposition to the breast. This allows near-total achievement of the purported benefi ts of both at the same time, while minimizing the trade-offs associated with selecting just one of the two pockets. It is therefore less of a compromise per se, than a way of “ having your cake and eating it, too ” , essentially doing both pockets at once, using each pocket where it exacts its greatest benefi t. While submammary and partial retropectoral are “ pure ” extremes, the dual plane is a continuous spectrum of options, occupying the “ gray-zone ” in between. The operation starts with the creation of a partial retropectoral pocket. The origins are carefully divided along the inframammary fold, which allows the cut edge of the muscle to glide a bit superiorly, so that there is both a small submammary and a large subpectoral area of the pocket, and hence the term dual plane. By disrupting attachments of the muscle to the overlying gland, the muscle can be gradually and incrementally raised, thereby reducing the proportion of subpectoral pocket and increasing the proportion of submammary pocket. The purported advantages of the partial retropectoral pocket are predominantly coverage along the sternum and over the superior border of the implant; the dual plane preserves these. The purported advantages of the submammary pocket are to direct implant pressure upon the lower pole; the dual plane preserves these as well ( Fig. 54.1 ). Criteria for the ideal pocket Our ability to determine the ideal pocket for a given situation rests upon the criteria that we choose to use to make that determination. Rather than vague, subjective decisions that allow certain issues to be overemphasized and others neglected, it is important to attempt to quantify all of the pertinent issues and measure each of the methods against them. Over the last several decades, published reoperation rates in PMA studies have not changed despite the use of different implants, remaining consistently at about 20% at three years. In a study of one device, a single surgeon achieved a 0% 675 Section 11: The breast Go to www.expertconsult.com to see updates to this chapter 0060_ch54_9780702031687.indd 675 4/8/2009 3:33:26 PM G Se breast augmentation dubai breast enlargement dubai breast implants dubai breast surgery dubai non surgical breast augmentation dubai breast surgery in uae boob job dubai ction 11: The breast Aesthetic Plastic Surgery 676 deforming and even uncorrectable. It is therefore not enough just to tally complications, but also to consider their severity. Dual plane data objectively show that this procedure succeeds in maintaining the advantages of both pockets while mitigating the trade-offs associated with selecting a single pocket. Preservation of future options in the event of an unsatisfactory outcome is important: if Plan A was still a viable option after Plan B, but Plan B would not be after Plan A, then that would suggest an advantage for starting with Plan B. Finally, outcomes need to be assessed at long intervals after surgery. Irrevocable, permanent, progressive, and at times totally uncorrectable changes occur to a breast years after an augmentation. Adequacy of tissue coverage needs to be judged at the longest possible intervals, decades if possible. Such long-term data is meager, but owing to the importance of such lifelong changes on the breast, at this point anecdote and extrapolation of shorter-term results should be considered ( Fig. 54.3 ; Table 54.1 ). Pain and recovery In general, there is less pain with the submammary approach, as the submuscular approach subjects the sensitive rib cage to possible trauma and the overlying muscle to stretching. But the largest data ever assembled on postoperative pain showed that 24-hour recovery without the use of any narcotics or pain pumps could be routinely achieved with a dual plane approach. Bloodless surgery and avoidance of creating any rib trauma circumvented the typical pain experienced from the rib cage in submuscular patients. Precise, gentle elevation, bloodless elevation of a pectoralis muscle paralyzed by the anesthesiologist results in a minimum of trauma to the muscle. This author has routinely been using these techniques for many years, and only uses ibuprofen for postoperative pain for routine augmentation mammaplasty in all planes, including the dual plane. Dual plane patients routinely go out to dinner, shower, and wash and brush their own hair the night of surgery. They describe the feeling as “ tight ” , a “ pressure ” , “ soreness ” , or “ like working out hard ” . Fig. 54.1 The three types of dual plane breast augmentation. A , Dual Plane Type I. B , Dual Plane Type II. C Dual Plane type III. A B Complete division along IMF C No division No division No division Fig. 54.2 Retromuscular pockets are often criticized for causing high-riding implants. In this case, the dissection was a blunt/blind transaxillary augmentation. The muscle was divided along the IMF on the left, but not the right. This is not a shortcoming of the procedure itself, but from its execution in this particular instance. 3-year reoperation rate in contrast to an average of 13.9% for all the doctors in the study. Taken together, these two fi ndings demonstrate that the outcome in breast augmentation is determined far less by the type of the device than by other factors ( Fig. 54.2 ). In the absence of data, surgeons must turn to the anecdotal. But when data is available, it trumps anecdote. Of all endpoints, the most decisive measurement of outcome is the reoperation rate, as it is an incontrovertible endpoint. “ Satisfi ed ” or “ happy ” patients are imprecise and unquantifi able endpoints, and since we have all seen unhappy patients with beautiful results and thrilled patients despite notable problems, they do not qualify as adequate endpoints with which to entirely judge the quality of an operation. The absolute incidence of reoperation tells only part of the story: the severity of a problem must also be considered. Some may be minor or annoying, while others may be 0060_ch54_9780702031687.indd 676 4/8/2009 3:33:26 PM G Chapter 54 The dual plane approach to breast augmentation 677 Fig. 54.3 A & C , Preoperative. B & D , Postoperative. Anecdotes are anecdotal, but sometimes that is the best that we have. If anyone doubts the importance of muscle coverage, they should be shown a series of patients with tissue so thin, with a saline implant looking like this, 11 years after surgery, free from capsular contracture, visible edges or rippling. Cases like this abound, but there are few examples of submammary or subfascial patients at this interval that look this good. A B C D When these same techniques are applied to the submammary approach, patients typically feel slightly less stiff and sore than do dual plane patients, but both groups still consistently achieve a “ 24-hour ” recovery. Any difference is subtle, noted only for a day or two, and is of no real consequence, particularly relative to advantages of achieving more muscle coverage. Coverage and stretch Soft tissue coverage is the single-most important issue affecting the short and long-term result after a breast augmentation. With adequate coverage, the implant edges are less visible, and the breast looks more natural and less augmented. Any folds or irregularities with the implant shell are more concealed. With more tissue over it, the device is less palpable. With less tissue coverage, the edges of the implant are more visible, the breast looks more augmented, and it is easier to feel the implant ( Fig. 54.4 ). Over the long term, these changes become more profound. Implants put pressure on the breast, and the parenchyma gradually compresses and atrophies. The presence of the implant stretches and thins skin. This occurs with implants in all positions. No study will ever randomize patients of similar tissue types and implant sizes and follow them over enough time for a scientifi c conclusion to be made. But a large amount of clinical observation and logic (see Fig. 54.3 and Fig. 54.5 ) offers us guidance. Examples of submammary patients with severe parenchymal atrophy abound, while retropectoral patients with similar characteristics are rarely seen. And when they are, though the implants may have ostensibly been placed “ behind the muscle ” , secondary surgery frequently reveals that the muscle has been avulsed off both the inframammary fold and sternum, thereby sacrifi cing the critical coverage of which we are speaking ( Fig. 54.6 ). These problems are sometimes noticeable within a year or two, but can often take years more to develop. We must be 0060_ch54_9780702031687.indd 677 4/8/2009 3:33:28 PM G Section 11: The breast Aesthetic Plastic Surgery 678 Table 54.1 Pocket comparisons breast augmentation dubai breast enlargement dubai breast implants dubai breast surgery dubai non surgical breast augmentation dubai breast surgery in uae boob job dubai Issue Advantage PRP Advantage subglandular Dual plane remedies Less pain X Best data to date Better coverage X Large advantage vs. SM; difference relative to PRP dependent upon release and up to determination of surgeon Access to lower pole parenchyma X Yes Expands constricted breasts X Yes Fills ptotic breasts X Yes Avoids muscle animation X Rarely clinically signifi cant Reduces tendency to “ ride high ” X Yes Reduces tendency to “ lateralize ” X Yes Faster recovery X Best data to date Less capsular contracture X Best data to date Better for mammograms X Appears to be Reduce parenchymal atrophy X Best data to date Reduces stretch deformities Best data to date Narrower cleavage X No – but subglandular can only do so at the expense of coverage Fig. 54.4 Tissue coverage is always a priority, particularly superiorly and medially. The implant she holds in her hand mimics what is occurring within her breast. With muscle coverage in the upper pole, such a deformity will rarely if ever occur. Fig. 54.5 This is not a capsular contracture. This is a submammary implant. The breast is soft. The patient chose this at the surgeon ’ s behest in order to avoid animation deformity. But even in repose, the signifi cant deformity is present; there is no substitute for soft tissue coverage. aware of these problems and remind ourselves that we need to create a result that will look good not just for years, but for decades. As someone who sees many secondary problems, I can state categorically that subglandular patients present more frequently, with more severe problems, and with more unsolvable problems than do subpectoral or dual plane patients. Such tissue thinning with submammary patients also is a set up for a problem which is diffi cult to correct, as to do so often requires a switch to the partial retropectoral or dual plane position. But once there is a subglandular pocket, the coverage in the retropectoral pocket is forever impaired. Though one can use sutures to tack the muscle back up to the gland, its caudal cut edge can never be retained as caudally as it might have been were this not to have happened, thereby forever impairing inferior coverage. Marionette pullout sutures have been described to hold down the muscle in this situation, but this also cannot achieve the same degree of 0060_ch54_9780702031687.indd 678 4/8/2009 3:33:31 PM G Chapter 54 The dual plane approach to breast augmentation 679 Fig. 54.6 This patient just had removal of subpectoral implants. The dotted line indicates the caudal border of the pectoralis. Though she had “ retromuscular ” pockets, the implant itself had negligible if any coverage as the muscle was so high it could cover only a bit of the implant, and the pressure of it probably pushed the implant away. Though her muscle was still attached to the sternum, the muscle had been inadvertently detached from the overlying parenchyma, thereby allowing it to window shade up far higher than would be ideal even for a DP III. Fig. 54.7 This patient had a submammary capsulectomy and then had a submuscular pocket dissected. It illustrates the basic principle of the DP approach. With no attachment of the muscle to the overlying parenchyma, this muscle window shades strongly superiorly. The DP approach recognizes the importance of maintaining those attachments when it is important to keep the muscle inferiorly to maintain coverage, and emphasizes the importance of a gradual and incremental release of them to allow controlled vertical elevation of the muscle and exposure of the parenchyma in the lower breast when the situation demands. Fig. 54.8 The most common argument for submammary placement is to deal with the postpartum involution and ptosis patient who does not want mastopexy scars. But this group has the thinnest tissue and is the most prone to stretch and thinning. A , A patient merely two years following such a procedure; note the extreme parenchymal atrophy and skin thinning. B , Note the improvement still noted two years after conversion to a dual plane. A B coverage as if the attachments between the muscle and the overlying gland were never disrupted ( Fig. 54.7 ). In conjunction with the thinning, there is often progressive stretch of the skin envelope, sometimes necessitating mastopexy. Even if this mastopexy would have been inevitable in the future with a partial retropectoral or dual plane pocket, such patients frequently have soft tissue thinning or capsular contractures in addition to the stretched skin. This necessitates a pocket change and possible capsulectomy in addition to the mastopexy, which can be a riskier procedure than if the implant had started out dual plane or partial retropectoral. This combination of secondary revision occurs so frequently that efforts must be made at the time of the original surgery so that this doesn ’ t happen ( Fig. 54.8 ; also see Fig. 54.5 ). If tissue coverage is adequate, it almost doesn ’ t matter what is going on with the implant; a capsular contracture may be less noticeable; suboptimal implant shape may be less problematic; implant folds might be harder to discern. These are powerful reasons to select the partial retropectoral pocket over the submammary pocket. But what should one do if there is glandular ptosis or a constricted lower pole and the tissue is thin? Partial retropectoral is preferred for the tissue coverage issue, but submammary may be necessary to allow better expansion of the lower pole. The dual plane solves this dilemma by allowing the upper and inner portion of the implant to be covered by muscle, while the inferior portion, the part that needs to push directly on the gland to expand and fi ll it, can be allowed to be in direct apposition. Achieving “ adequate ” coverage is an insuffi cient goal. “ Maximum ” coverage must be the goal. There is almost no long-term problem that is not solvable when substantial soft tissue is available, and there are few problems completely correctable when soft tissue is not available. There is some sacrifi ce in coverage with the dual plane relative to partial retropectoral, and if tissue coverage in the lower pole is such that the benefi ts of changing to the dual plane do not outweigh its advantages, then it is suggested to patients to have a partial retropectoral pocket. In any case, the reduction in coverage with the dual 0060_ch54_9780702031687.indd 679 4/8/2009 3:33:33 PM G Section 11: The breast Aesthetic Plastic Surgery 680 plane relative to partial retropectoral is reasoned and controlled. Access to parenchyma The most profound advantage of submammary over partial retropectoral is attributable to the direct pressure the implant can make against the gland. This can make it look less empty, and the pressure can better expand a tight lower pole. If behind the muscle, the muscle essentially protects the preexisting confi guration of the lower pole, inhibiting the implant ’ s ability to push it and fi ll it out. And if weak fi brous connections between the pectoralis muscle and breast gland allow the gland to slipe relative to the muscle, placing the implant against the breast tissue can help reduce the extent of inferior tissue migration. Otherwise, the subpectoral placement still allows the gland to slide inferiorly relative to the muscle ( Figs 54.9 and 54.10 ). Depending upon the degree of release with the dual plane, these advantages of the submammary approach can be almost completely if not completely realized with the dual plane approach. The coverage that is preserved superiorly and medially typically allows for muscle coverage where it is most needed: superiorly and along the medial sternal border. Capsular contracture Capsular contracture still remains the leading cause of reoperation in PMA studies, yet publications using antibiotic irrigation and the dual plane pocket have resulted in some of the lowest reported capsular contracture rates to date. Whether it is specifi cally due to the dual plane per se or other factors, such as the irrigation, is not entirely clear. But it is suffi cient to say that the lowest reported capsular contracture rates are with the dual plane position, and no paper suggests an advantage to partial retropectoral over dual plane. Dual plane is the ideal choice. Mammography Given the cancer prone nature of the breast, optimizing the ability to detect cancer early must remain a priority. Numer- Fig. 54.9 The long term stability of the outcome in this post partum atrophy/ptosis patient with implants in the dual plane position demonstrates the value of proper implant sizing and tissue coverage. pre 5 months 1 yr 2 yrs 3 yrs 5 yrs 0060_ch54_9780702031687.indd 680 4/8/2009 3:33:37 PM G Chapter 54 The dual plane approach to breast augmentation 681 ous authors have suggested an advantage to retropectoral over submammary placement for this regard, but it is unclear whether the advantage is directly due to the anatomic location relative the muscle itself, or due to a lower capsular contracture rate below the muscle. Suffi ce to say, mammogram is impaired when the breast tissue cannot be pulled out and away from the implant and placed between the mammogram plates, such as when the implant is hard, there is a large implant relative to the breast tissue, or any other reason that restricts the pull of the tissue forward. While no studies have specifi cally compared sensitivity of mammogram between these pockets over a long period of time, the low incidence of capsular contractures and the extensive muscular coverage over a dual plane implant suggests that this would not be a problem. In any case, the role of MRI in screening for breast cancer is increasing, even for women without breast implants. And since implants do not affect its sensitivity, this entire issue may soon be moot. Muscle animation The lack of signifi cant implant motion or distortion with contraction of the pectoralis is a signifi cant advantage of the submammary position relative to the partial retropectoral pocket. But it is not enough to look at the problematic subpectoral patients with animation problems: one must also be aware of the submammary patients with signifi cant implant visibility even in repose. The deformity of a thin patient with subglandular implants at rest is typically more profound than a partial retropectoral patient during maximal contracture. With the dual plane approach, the release of the pectoralis along the inframammary fold (IMF) reduces if not totally eliminates the forces that might distract the implant superiorly. While the medial origins along the sternum may compress and slightly lateralize the implant on strong contraction, they rarely cause a signifi cant deformity ( Fig. 54.11 ). Fig. 54.10 The constricted lower pole breast is frequently touted as being a reason for submammary, as it allows scoring of the lower pole. In this case, shown here at 5 years post-surgery, a DP II was done, allowing the muscle to rise to the lower border of the areola. This exposed parenchyma for the entire lower pole of the breast, allowing it to be shaped just as much as it would have been were this to have been a submammary placement, but with maintenance of muscle coverage superiorly and medially, which helps to obscure the borders of the implant. 0060_ch54_9780702031687.indd 681 4/8/2009 3:33:39 PM G Section 11: The breast Aesthetic Plastic Surgery 682 Certainly, there is some motion, but in the Tebbetts series, there was no revision requested for this reason. In my experience, there has been occasional complaint and discussion of revision, but I have not switched my own patient to a submammary pocket for this reason ( Fig. 54.12 ). Usually, the patients with any such problems are very thin, and were therefore the least well suited for a submammary pocket. The key in minimizing animation with the dual plane pocket is to uniformly and accurately take the muscle down along the inframammary fold, stopping evenly on both sides at the point at which the IMF meets the sternum, and never releasing along the sternum. It appears that when the IMF is horizontal and meets the sternum at a discrete point, these issues are less problematic than when the IMF curves sharply superiorly as it moves towards the sternum, oftentimes not actually meeting the sternum until being at or even above the level of the nipple. These patients are also often thin, and they represent a particular challenge, in that there in fact may be no way to avoid some deformity with either approach. Fig. 54.11 A critical step of all dual planes – I, II, and III – is to completely divide the pectoralis major along the inframmary fold, stopping at the sternum, without division along the sternum. Failure to divide the origins along the IMF result in either a high-riding implant, superior malposition with animation, or a blunted IMF. However, if tissue coverage is thin ( < 5 mm), they probably should not be divided, as maintaining coverage is the fi rst priority. Division along the sternum can result in symmastia, excessive edge visibility and uncorrectable deformities. Complete division along IMF No division Fig. 54.12 DP and all retromuscular pockets are criticized for animation deformities. But the patient needs to be considered in repose as well. Here the same patient on the top is seen submammary, relaxed in two different poses. Though there is no animation deformity, the implants are unattractive. In the lower left, she is shown relaxed in the DP position, looking much prettier and more natural. In the lower right, she does demonstrate distortion with contracture, but no doubt even if this is the maximal distortion she can manage, it is still less deformed than she looks in either of the preoperative views in repose. 0060_ch54_9780702031687.indd 682 4/8/2009 3:33:44 PM G Chapter 54 The dual plane approach to breast augmentation 683 No matter which pocket is selected, the patient must be fully informed preoperatively of the trade-offs, and participate in the pocket selection. That way, if she has an animation deformity or implant deformity later, she can be reminded that she preferred accepting that problem to the risks of the other pocket. If a patient is not made aware of these choices preoperatively, then dissatisfaction and request for revision remain avoidable risks for revision. Narrower cleavage Both partial retropectoral and dual plane procedures accept the inner border of the pectoralis major muscle as an absolute limit to the medial placement of the implants. Once submammary, the implant can certainly be more medial. However, this comes at a price: the patients who most request or “ need ” such medialization invariably have the least soft tissue cover, and moving the implant medial to where the internal border of the pectoralis origin on the sternum results in risking symmastia and excessively visible implant edges. It is foolhardy to attempt to create cleavage by excessive medial placement of any implant, as tight skin usually pushes the implant laterally and the thin skin results in distinctly visible edges. So while the submammary does have the potential to place implants more medially, this amounts to more of a liability than an advantage. Physical evaluation Until experienced, most surgeons believe that an operation is all about what happens the day of surgery. In fact, it is the decisions that lead up to surgery that often have the most long-term effects on a result. This is particularly true of breast augmentation, where patient wishes, patient anatomy, and surgeon judgment converge. This topic is more important than pocket choice or any other issue with breast augmentation alone. The following are the most important of these points: Patient education The patient must be informed about the limitations of her tissue, so that her expectations are met. She must anticipate all trade-offs with respect to issues such as tissue coverage, animation, correction of ptosis, etc. When patients participate in these choices and sign off on them, the incidence of revision surgery is reduced and patient satisfaction increases. Determination of ideal implant size A patient is asked to decide whether she wants an implant that fi ts properly within her tissue, or she wants to force a certain size into her breasts without regard for creating an unnatural result in the short term and causing permanent tissue changes in the long term. Informed patients will usually select the latter. In that case, using the base width, skin stretch, and degree of envelope fi ll, the ideal implant size for that patient ’ s breast is determined. Larger will have an upper convexity and look more full, stuffed, or fake. Smaller will have a concave upper pole and look emptier. breast augmentation dubai breast enlargement dubai breast implants dubai breast surgery dubai non surgical breast augmentation dubai breast surgery in uae boob job dubai Determination of need for coverage and for muscle release The dual plane preserves coverage and allowing coverage where it is needed. These two opposing characteristics need to be evaluated in all patients. Coverage It is always a goal to maintain as much coverage as possible, sacrifi cing coverage only when there is a reason to do so. With the exception of patient request (after being fully informed), a dual-plane approach is suggested to all. If coverage is < 2 cm of pinch at the upper pole, then a submammary approach will not even be offered. If pinch < 5 mm at the IMF, serious consideration is given to not releasing the muscle to create the dual plane, choosing instead to use a partial retropectoral pocket. In such situations, the long-term benefi ts of preserving maximal coverage often outweigh animation deformities, widening of the intermammary distance, and the predictability and crispness of the inframammary fold position. Muscle release The breast is examined for lower pole constriction or glandular ptosis that might necessitate controlled release of the muscle from the gland. While one might decide specifi cally preoperatively to perform a dual plane type II or type III, the surgeon should always start by dissection a type I, and then examine and feel the breast, releasing as much as is necessary during the operation. Need for mastopexy Many patients see plastic surgeons for a breast augmentation following lactation or weight loss. For some of these women, mastopexy is the appropriate procedure. Not wanting scars, some of these patients either receive an implant that fi lls, but is larger than they wish, or an implant of the size they want but which creates inadequate fi ll. In either case, and in particular in the case of the larger implants, the result is aesthetically compromised, and the already stretched skin stretches more and deteriorates with time. I have seen many such patients who had received submammary augmentations, and have tried this on my own patients. If followed long enough, the results are frequently unsatisfactory. Neither is the dual plan an answer for these patients; if the nipple (N) is below the fold, if N : IMF distance is > 9.5 cm on maximum stretch, or if substantial parenchyma lays caudal to the inframammary fold, mastopexy must be considered, and augmentation should either not be attempted or only performed on the patient who clearly demonstrates an understanding of the limitations of such a procedure (see Fig. 54.8 ). Anatomy The pectoralis major muscle has origins along the clavicle, sternum, and the 4th – 6th ribs along the IMF, and inserts onto the humerus, causing fl exion and internal rotation. Studies 0060_ch54_9780702031687.indd 683 4/8/2009 3:33:48 PM G Section 11: The breast Aesthetic Plastic Surgery 684 have demonstrated that the pectoralis origins along the IMF can be released without loss of strength or coordination. What is most relevant to the dual plane is the recognition that the deep surface of the pectoralis glides over the chest wall. It is anchored like a trampoline on three sides to the humerus, clavicle, and ribs. Like a trampoline released on one edge, the muscle will retract strongly away from the side of the release. The only thing that holds it in place – in distinct contrast to its deep surface – is that its superfi cial surface is tightly bound to the deep surface of the gland. The superfi cial surface of the muscle gives rise to the Cooper ’ s ligaments and fi brous tissue that ramify throughout the breast. These attachments help hold the caudal edge of the muscle inferiorly, thereby maintaining coverage to the lower pole of the implant. Following careful release of the muscle along the inframammary fold, the surgeon will observe the muscle “ window shade ” , sliding superiorly 1 – 2 cm. However, if there was an inadvertent dissection on the superfi cial surface of the muscle, thereby disrupting some of the fi bers connecting the muscle to the overlying gland, the muscle will window shade far more, sacrifi cing what might be intended coverage of the lower pole. This point is most emphasized when creating a retropectoral pocket following a submammary capsulectomy. Even if the pectoralis origins along the IMF are left intact, the caudal edge of the muscle window shades very high superiorly; if those origins are released, it may move so high that it cannot even cover the implant at all. Understanding this dynamic is critical to the dual plane approach. Technical steps See Table 54.2 ; see also Fig. 54.1 . Though a dual plane dissection can be done from all incisions, the inframammary incision allows the greatest degree of visualization and control of the dual plane pocket. Most specifi cally, it allows preservation of all the attachments between the muscle and the overlying gland, so that if they need to be dissected, it can be done in a specifi c and controlled manner. Dissection from the periareolar incision down to the inframammary fold or the proposed level of transection of the muscle invariably results in some degree of inadvertent disconnection of the muscle from the overlying gland, thereby resulting in unintentional superior elevation of the muscle, creating for example a dual plane type II or III when a type I was the goal. I frequently perform revision surgery on patients who had periareolar augmentation in which the operative note described the procedure as “ partial retropectoral ” and described only division of the muscle along the inframammary fold, yet the caudal edge of the muscle is frequently found well above the upper border of the areola, beyond what is even considered a dual plane III. This may be due to a combination of a bit of release of the muscle along the sternum, but it seems more commonly due to a release of the attachments of the superfi cial surface of the muscle from the gland simply as part of the tunneling process to reach the inframammary fold. Unless a DP II or III is a goal, a surgeon should probably perform dual plane pocket surgery from the inframammary incision until they have gained substantial experience. Many surgeons divide the muscle along the inframammary fold and describe the procedure as “ half over – half under ” , or even “ partial retropectoral ” , which is exactly what is described as a dual plane type I. Whatever the label, these surgeons should always be cognizant that the loss of tissue coverage from a periareolar incision is always a risk unless extremely fastidious dissection is done. Table 54.2 Technical steps Description Indication Goal Partial retropectoral Pectoralis attached to sternum and to IMF IMF pinch < 5 mm Maintain maximum coverage Dual plane type I Same plus complete division of pectoralis along IMF All parenchyma above IMF; gland adherent to muscle; A : IMF on maximum stretch 4 – 6 cm Small sacrifi ce in coverage to increase IMF accuracy; reduce animation deformity; allow implant to sit at bottom of pocket Dual plane type II Same plus pectoralis released from overlying gland and allowed to slide to about the lower border of the areola Most parenchyma above IMF; looser attachments of gland to muscle with some sliding of gland over muscle; stretched lower pole skin with A : IMF under maximum stretch 5.5 – 6.5 cm More sacrifi ce in lower pole muscle coverage in order to reduce risk of mobile breast augmentation dubai breast enlargement dubai breast implants dubai breast surgery dubai non surgical breast augmentation dubai breast surgery in uae boob job dubai parenchyma from sliding off of muscle, better fi ll of loose envelope Dual plane type III Same plus greater release of pectoralis from gland, allowing it to slide to about the upper border of the areola Ptosis with one-third or more of parenchyma below level of anticipated IMF with patient standing; substantial sliding of gland over muscle; more stretched lower pole skin with A : IMF under max stretch 7 – 8 cm or constricted lower pole breasts Most sacrifi ce in lower pole muscle coverage to allow maximal contact of implant against gland; allows for maximal scoring/reshaping of gland to allow maximal expansion 0060_ch54_9780702031687.indd 684 4/8/2009 3:33:48 PM G Chapter 54 The dual plane approach to breast augmentation 685 Likewise, a DP I, involving only the release of the pectoralis along the inframammary fold, can be undertaken from the transaxillary incision. Unlike a blunt and blind transaxillary approach which risks uneven release of the muscle and imprecise level of the inframammary fold, a true DP I transaxillary should be done with a bloodless, endoscopic technique. Creating a DPII or III, however, involves retrograde dissection from the transaxillary incision. This remains on the technical fringe at this time, and should be undertaken by surgeons experienced with endoscopic transaxillary partial retropectoral pocket creation after experience with the dual plane for a variety of situations from the inframammary incision. IMF approach See Fig. 54.13 . The fi rst step is to determine the ideal position of the inframammary fold. It is calculated from the nipple with the tissue placed on maximum stretch. In general, the standard of 7 cm for a base width of 11 cm, 8 cm for a base width of 12 cm, and 9 cm for a base width of 13 cm holds true. If the inframammary fold is already at that height, it does not need to be altered. An incision is made at the proposed inframammary fold. Dissection is carried straight down to the muscle fascia with the electrocautery, taking care not to skive inferiorly. There is a natural tendency of the cut edge of the tissue to pull inferiorly, so the dissection may angle superiorly, but only for the purpose of not undercutting the skin edge and inadvertently lowering the fold more than intended, if at all. The fascia is scored carefully with the cautery, so that the muscle is visible. Place in a double-ended or army-navy retractor with the tip pointed towards the medial border of the areola. With no horizontal dissection yet made, there will be little to hold the tissue up onto the blade of the retractor, so use the ulnar fi ngers of the retractor holding hand to pull the tissue onto the blade. Lift up towards the ceiling. Only the pectoralis will tent up. If the muscle does not tent at this point, it may be that the muscle is tight, or it may be that it is not the pectoralis. To ensure that it is pectoralis, and neither serratus, rectus, nor intercostals, touching it with the cautery will make the pectoralis in the upper chest contract. If still not clear, only then dissect just a couple of millimeters along the muscle surface in a cephalad direction. These are the important fi bers that you want to preserve in order to hold the muscle down after you release along the inframammary fold, so sacrifi ce no more than necessary for the anatomy to be clear. This will allow you to see the fi bers of the muscle, and allow some tissue to lie over the blade of the retractor, thereby allowing the pectoralis to tent up. Again advance the retractor blade to the edge of the muscle, pointing the blade to the medial border of the areola, pulling the breast tissue onto the retractor, and lifting toward the ceiling. Because it is loose on its deep surface, the pectoralis will tent upwards. Holding your hand down onto the abdomen so that the cautery is horizontal, sweep gently the taught pectoralis fi bers that appear vertical in front of you. Use hand switching monopolar forceps, as it allows precise control of blood vessels by squeezing, but so too can it be held together and used as a Bovie pencil. So long as it tents, it is pectoralis. So long as your cautery is horizontal and parallel to the chest wall, the chest is safe. Keep advancing the retractor forward and lifting up after every stroke of the cautery. With each motion of the cautery and repositioning of the retractor, the muscle will tent higher and the plane through the muscle will become more obvious. With this maneuver, you will very quickly get through the muscle, and will see the subpectoral space. Free up areolar tissue that is immediately in front of the incision, and then turn the retractor blade medially along the inframammary fold towards the sternum. Controlling the tension of the retractor blade on the muscles with fi ngers on the outside of the breast, use the cautery to take down the muscle about 1 cm above the proposed inframammary fold. This may serve as a shelf to help support the implant; it prevents over lowering of the fold; and it allows point coagulation of intramuscular blood vessels. Cut through the muscle and the overlying fascia. This should be bloodless and very easy to visualize. In fact, this dissection is so anatomic, that you should expect to be able to do it without needing to place a single four by eight into the pocket. Look beyond the tissue plane immediately in front of you, anticipating and seeing the perforators ahead of time. Continue all the way to the sternum, but do not proceed up the sternum at all. If you are unclear where this point is, mark it with an “ X ” externally on both sides preoperatively. Continue the dissection sweeping superolaterally, and then sweeping inferiorly. This helps to fi nd the plane between the pectoralis major and pectoralis minor, which are more intertwined if the dissection in that area starts inferolaterally instead of superolaterally. Irrigate with antibiotic solution and inspect the pocket. Take note of the long, narrow V -shaped trough where the muscle was released inferomedially and window shaded a bit superiorly. Inspect where the cut edge of the pectoralis is relative to your incision; sometimes it is just a few millimeters beyond it, and sometimes it is already window-shaded several centimeters. This will vary based upon how cleanly you got through the pectoralis and how tight the given patient ’ s connections between the pectoralis and breast tissue are. Place a fi nger in the incision and feel the lower border of the muscle and lift up, taking note of the position of the muscle through the skin as shown by the position of your fi nger. This inspection process is not just important in order to defi ne what you need to do for that specifi c patient, but done repeatedly, it provides the surgeon with a valuable experience about the dynamics of the muscle and the soft tissue. If the intention is to do a dual plane I, by virtue of the muscle release, the dual plane portion of the dissection is complete. The implant can be placed and the incision closed. If the goal is to do a dual plane type II or type III, then now is the time to do a release. This release is gradual and incremental. It cannot be overstated that substantial differences in position of the caudal edge of the pectoralis are created by just several millimeters of dissection. Surgeons ask 0060_ch54_9780702031687.indd 685 4/8/2009 3:33:48 PM G Section 11: The breast Aesthetic Plastic Surgery Fig. 54.13 A & B , After the retropectoral pocket is made, the pectoralis is divided 1 cm above the proposed inframammary fold. Note the use of the ulnar digits on the retractor hand pressing the muscle under tension so that it splits as it is divided. The superior and inferior cut edges are visible. When this is divided up to the sternum, a dual plane I will have been created, as shown in this photo. Depending upon the tension of the tissues, the muscle will window shade up a centimeter or two; in this case the muscle is about half the width of the retractor blade above the IMF. C , To go from a dual plane I to a II or III, the fi brous connections between muscle and the overlying parenchyma must be taken down. Just a few sideways swipes with the cautery is enough to cause signifi cant movement of the muscle. D , After just a few swipes of the cautery freeing up some attachments of the muscle to the gland, the muscle moves cephalad. The fresh yellow fat shows the signifi cant motion of the muscle relative to the last photo. Again, note the use of the ulnar digits against the retractor to create tension at the muscle parenchyma border, thereby making the dissection more precise and facile. E , When converting to a DP I to a II or a III, note how the hand and the retractor are used as a unit to create tension at the muscle/parenchyma interface. F , Here the release is being done more laterally. It can be adjusted on each breast exactly as the conditions necessitate. G , Copious irrigations with “ Adams ” solution (50 mL Betadine, 80 mg gentamicin, 1 g Ancef in 500 mL NS) is used throughout the operation. Note the yellow fat visible just beyond retractor; cut edge of muscle is just visible. H , In this case, the muscle is released to the lower border of the areola, which is a so-called dual plane II. When it is released to about the upper border of the areola, it is termed a DP III. A G H E F C D B 0060_ch54_9780702031687.indd 686 4/8/2009 3:33:49 PM G Chapter 54 The dual plane approach to breast augmentation 687 why they can ’ t dissect between the muscle and the gland before the muscle dissection, and the reason is that such small amounts of dissection result in such signifi cant movement of the muscle, that it is impossible to predict where the muscle will end up before dissecting the pocket and releasing the IMF. With the curved end of a double-ended retractor placed in the incision, abutting to the caudal edge of the muscle, but with only breast tissue within it, use the other fi ngers in the retractor hand to push in on the breast, so that together with the retractor, it is putting tension between the muscle and the overlying gland. Visualize the fascial connections between the muscle and gland, and use the cautery to gradually cut these, using sideways sweeping motions. You will see the muscle quickly pull away from the retractor and slide upwards. Once it does this even for several millimeters, move the retractor medially and laterally and repeat this process where you feel there is restriction by the muscle. Rather than repeating this motion in the same area, keep moving around, as this will give the most control over the fi nal position of the muscle. While illustrations suggest dual plane type I, II, and III as distinct entities, they are part of a continuum of options. Their designations are designed as a guide to enable us to think about a clinical situation and compare notes. But in any given patient, the muscle does not necessarily end exactly at the lower border of the areola (type II) or the upper border of the areola (type III). Rather, the release is made to the extent that is necessary to achieve the exposure of the implant to the gland of the breast. The most important point is not to overdo it. You can always release more, but once it is released, it is diffi cult if not impossible to pull the muscle back down. Put your fi nger back in as you did before, and note the chance in position of the muscle relative to before you did the release. Feel all along its edge, and go back and release more where you feel it is necessary. If you feel bands within the breast that are restricting expansion, such as with a constricted lower pole, or when the IMF had to be lowered with a tight IMF, now would be the time to score the lower pole, much as you might have done with a submammary pocket. Irrigate again with antibiotic solution, recheck for bleeding, and place the chosen implant close per the usual routine. Postoperative care With precise visualization of the pocket, no special bras or straps are necessary to try to push the implant into a pocket. Tape or a Steri-strip over the incision is the only dressing that is used. With bloodless dissection, no special bandages are necessary to create compression, and early motion is not just allowed, it is ordered. Patients move their arms over their head in the recovery room in a gradual jumping jack type of motion. They go home, take a nap, and then are instructed to continue their exercises every hour while awake, take a shower, and leave the house for dinner. They may drive a car when they feel that they can safely make unrestricted movements, which is usually in two to four days. They are encouraged to do all normal daily activities that do not involve particular exertion, such as opening and closing car doors, putting on a seatbelt, lifting a baby, emptying a dishwasher, or making dinner. They may return to the gym after three weeks, though some surgeons allow this after two weeks. With gentle, precise, and bloodless dissection, patients are only given narcotics through their time in the recovery room, and are managed over 95% of the time with ibuprofen alone at home. Complications There is no complication of dual plane that has not been well-described with either the submammary or partial retropectoral operations. The issue with dual plane is not that there are new complications, but that the patient and surgeon understand its limitations. So long as these trade-offs are well understood preoperatively, they are accepted later. For instance, in cases of extreme mobility of the breast over the underlying chest wall, inferior sliding of tissue may still occur with the dual plane approach. It is my impression that in extreme cases of laxity this may occur more with the dual plane than the submammary approach, but this is diffi cult to quantify because even the submammary approach does not always totally solve the problem. Though dual plane can reduce muscle animation relative to partial retropectoral, it cannot eliminate it to the same extent as the submammary pocket. Patients need to be aware of this, and make their decision about the pocket they prefer. 0060_ch54_9780702031687.indd 687 4/8/2009 3:33:53 PM G Pearls & pitfalls Pearls • When you have a choice in breast augmentation, always prioritize coverage. This will make the breast more natural in the short term and reduce the likelihood of diffi cult to correct long-term problems. • Point out all limitations a patient ’ s pre-existing anatomy poses on her result preoperatively. This will help her to let you do what you think is best for her, and will prepare her to accept trade-offs and shortcomings in her result later. • With the dual plane, dissect a partial retropectoral pocket fi rst. The more directly you are able to get behind the muscle, the less it will move superiorly after muscle division. • Do not force yourself to choose which type of dual plane you will do; these are not so much distinct entities as points on a path. You should feel the breast during the dissection and adjust the dissection accordingly. • Demand of yourself to make a gentle and bloodless pocket dissection so that your patients have an easy recovery. Pitfalls • The dual plane is not perfect, and though it maximizes most of the advantages and minimizes most of the disadvantages of either the submammary or partial retropectoral pockets, neither the surgeon nor the patient should think that it is perfect. • It is easy to over-dissect the attachments between the muscle and gland; avoid excessive dissection in that plane before dividing the pectoralis along the IMF, and then only release gradually and incrementally. • Do not release the pectoralis ever along the sternum; it creates deformities that are diffi cult to correct. Summary of steps 1. Partial retropectoral: Pectoralis origins left intact along sternum and IMF. 2. Dual plane type I: Pectoralis origins left intact along sternum, but divided along the IMF. 3. Dual plane type II: Same plus pectoralis released from overlying gland and allowed to slide to about the lower border of the areola. 4. Dual plane type III: Same plus greater release of pectoralis from gland, allowing it to slide to about the upper border of the areola. Further reading Adams WP Jr . The process of breast augmentation: Four sequential steps for optimizing outcomes for patients . Plast Reconstr Surg 2008 ; 122 ( 6 ): 1892 – 1900 . Adams WP Jr , Rios JL , Smith SJ . Enhancing patient outcomes in aesthetic and reconstructive breast surgery using triple antibiotic breast irrigation: Six-year prospective clinical study . Plast Reconstr Surg 2006 ; 118 ( 7S ): 46S – 52S . Spear SL , Carter ME , Ganz JC . The correction of capsular contracture by conversion to “ dual-plane ” positioning: Technique and outcomes . Plast Reconstr Surg 2006 ; 118 ( 7S ): 103S – 113S . Tebbetts JB , Adams WP . Five critical decisions in breast augmentation using fi ve measurements in 5 minutes: The high fi ve decision support process . Plast Reconstr Surg 2006 ; 118 ( 7S ): 35S – 45S . Tebbetts JB . Achieving a zero percent reoperation rate at 3 years in a 50-consecutive-case augmentation mammaplasty premarket approval study . Plast Reconstr Surg 2006 ; 118 ( 6 ): 1453 – 1457 . Teitelbaum S . The Inframammary approach to breast augmentation . Clin Plast Surg 2009 ; 36 ( 1 ): 33 – 43 Section 11: The breast Aesthetic Plastic Surgery 688 0060_ch54_9780702031687.indd 688 4/8/2009 3:33:53 PM